ERECTION DYMENTS (ED) Directive - American Urological Association (2024)

1. Shea BJ, Hamel C, Wells GA et al: Amstar is a reliable and valid measuring instrument to assess the methodological quality of systematic reviews.J Clin Epidemiol 2009;62:1013.

2. Cochrane Handbook for systematic assessments of interventions.Chichester, West Sussex;Hoboken, NJ: John Wiley & Sons 2008.

3. Faraday M, Hubbard H, Kosiak B et al: Stay in the foreground: an overview and analysis of evidence reporting and classification;104:294.

4. HSU C and Sandford B: Delphi technology: Gives a sense of consensus.Practic Assessment, Research and Evaluation 2007;12:1.

5. impotens.nih consensus statement 1992;10:1.

6. McCabe MP, Sharlip ID, Atalla e et al: Definitions of sexual dysfunctions in women and men: a consensus statement of the fourth international consultation on sexual medicine 2015. J Sex with 2016;13:135.

7. Saigal CS, Wessells H, Pace J et al: Predictors and performance of erectile dysfunction in a racially diverse population.Arch internal with 2006;166:207.

8. Bacon CG, Mittleman Ma, Kawachi in et al: a prospective study of risk factors for erectile dysfunction.J Urol 2006;176:217.

9. Elwyn G, Frosch D, Thomson r et al: shared decision -making: a model for clinical practice.J Gen internal with 2012;27:1361.

10. Epstein RM, Alps BS and Quill Tea: communication of proof of participating decision -making.Jama 2004;291:2359.

11. Hoffmann TC and Share Mar C: The patient's expectations for the benefits and damage of treatments, screening and testing: a systematic review.jama internally with 2015;175:274.

12. Hatzichristou D, Rosen RC, Derogatis Lr et al: recommendations for clinical evaluation of men and women with sexual dysfunction.J sex with 2010;7:337.

13. Vemulakonda VM, Sorensen MD and Joyner BD: the current state of diversity and multicultural training in Urological Residence programs.J Urol 2008;180:668.

14. McKinlay JB: The worldwide prevent and epidemiology of erectile dysfunction.Int J Impot Res 2000;12 Suppl 4:CSS

15. Ayta IA, McKinlay JB and Krane RJ: the likely global increase in erectile dysfunction between 1995 and 2025 and some possible political consequences.Bju int 1999;84:50.

16. Jackson G, Boon N, Eardley in et al: erectile dysfunction and prediction of the coronary arteries: evidence -based guidelines and consensus.int J Clin Pract 2010;64:848.

17. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada in et al: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the epidemiology of the erectile dysfunction Dysfunction study.j Urol 2001;166:569.

18. Corona G, Lee DM, Forti G et al: Age -related changes in general and sexual health in middle and older men: results of the European Male Aging Study (EMAS) .J Sex with 2010;7:1362.

19. Feldman Ha, Goldstein I, Hatzichristou DG et al: Impotence and his medical and psychosocial correlates: results of the male aging study of Massachusett.j Urol 1994;151:54.

20. Grover SA, Lowensteyn I, Kaouache M et al: The occurrence of erectile dysfunction in primary care: the importance of risk factors for diabetes and vascular diseases.166:213.

21. Sassayamas, She N, Ishikur f et al: Men's Health Survey: epidemic of erectile dysfunction and Hart -car -sickness.circ is J 2003;67:656.

22. Clones RA: erectile dysfunction of the heart patient.curr Urol Rep 2003;4:466.

23. Montorsi P, Ravagnani PM, Galli s et al: The triad of endotel -Dysfunction, heart -car -sylus and erectile dysfunction: clinical implications.8:58.

24. El-Sakka AI: Association of risk factors and medical comorbidities with male sexual dysfunctions.J sex with 2007;4:1691.

25. Hodges LD, Kirby M, Solanki J et al: The temporal relationship between erectile dysfunction and Hart -Seside -Seaside.int J Clin Practice 2007;61:2019.

26. Montorsi F, Briganti A, Salonia a et al: Prevalence of erectile dysfunction, the start and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease.EUR UROL 2003;44:360.

27. Inman Ba, Saver JL, Jacobson DJ et al: a population -based, longitudinal study of erectile dysfunction and future coronary artery disease.Mayo CLIN PROC 2009;84:108.

28. Fung mm, Bettencourt R and Barrett-Connor E: Risk factors for heart disease predicts 25 years later erectile dysfunction: Rancho Bernardo Study.j am Coll Cardiol 2004;43:1405.

29. Esposto K, Giugliano F, Martedi e et al: High proportions of erectile dysfunction in men with metbolic syndrom.iabetes care 2005;28:1201.

30. Ansong KS, Lewis C, Jenkins p et al: Epidemiology of erectile dysfunction: a society -based study in rural areas of New York.An epidemiol 2000;10:293.

31. Nwanko T, Yoon S, Burt V et al: Hypertension Blandt Voksne I USA: National Health and Nutrition Examination Survey, 2011-2012.Hyattsville, MD: National Center for Health Statistics 2013.

32.120:151.

33.171:2341.

34. Rosen RC, Fisher Wa, Eardley in et al: The multinational attitude of men towards life events and sexuality (men) study: I. The spread of erectile dysfunction and related health problems in the general population.Look with res Opin 2004;20:607.

35. Manolis A and Doumas M: Sexual dysfunction: 'Great ballerina' of hypertension-related quality of life complications.J Hypertens 2008;26:2074.

36. Toth pp, Potter D and Ming Ee: Distribution of lipid abnormalities in the United States: National Health and Nutrition Examination Survey 2003-2006.j Clin Lipidol 2012;6:325.

37. Eaton CB, Liu Yl, Mittleman Ma et al: a retrospective study of the relationship between biomarkers for atherosclerosis and erectile dysfunction of 988 men.Thin J Impot Res 2007;19:218.

38. Romeo JH, Seftel Ad, Madhun ZT et al: Sexual function in men with type 2 diabetes: Association with glycemic control.J UROL 2000;163:788.

39. Bacon CG, HU FB, Giovannucci et al: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men ..Abetes Care 2002;25:1458.

40. Braun MH, SUMMER F, Haupt GT Al: Lower urinary court symptoms and erectile dysfunction: comorbidity or typical "aging man" symptoms?44:588.

41. Hoesl CE, Woll EM, Burkart M et al: Erection dysfunction (ED) is widespread, nuisance and under -diagnosis in patients consulting urologists for benign prostatas syndrome (BPS).Eeur Urol 2005;47:511.

42. Rosen R, Altwein J, Boyle P et al: lower urinary tract symptoms and male sexual dysfunction: the multinational examination of the aging man (MSAM-7).EUR UROL 2003;44:637.

43. Gonzalez RR and Kaplan SA: Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.2:609.

44. KAPLAN HS: The new sex therapy: Active treatment of sexual dysfunctions: Brunner/Mazel 1974.

45. Masters W, Johnson, V: Human Sexual Reacties.New York, New: Little, Brown and Co.1966.

46. ​​Marwick C: Study says that patients expect some doctor's assistance with sex.Jama 1999;281:2173.

47. Althof See, Rosen RC, Perelman Ma et al: Standard Operations Procedures to take a sexual history.J sex with 2013;10:26.

48. Sereefoglu EC, McMahon CG, Waldinger MD et al: A general definition of lifelong and acquired premature ejacul*tion based on evidence -based: report of the other international community for sexual medical addicts on the definition of premature ejacul*tion.sex by 2014;2:41.

49. Lee JH, ngengwe r, Jones p et al: erectile dysfunction as a risk of a coronary arterial disease equivalent.j nucl cardiol 2008;15:800.

50. Fillo J, Levcikova M, ONDRUSOVA MT AL: The meaning of different qualities of the abdominal obesity on testosterone levels, erectile dysfunction and clinical coincidence.Am J Mens Health 2017;11:240.

51. Ghanem HM, Salonia A and Martin-Morales A: SOP: Physical examination and laboratory test for men with erectile dysfunction.J sex with 2013;10:108.

52. McCabe MP and Althof See: A systematic review of the psychosocial results associated with erectile dysfunction: stretching the effect of erectile dysfunction outside the inability of a man to have sex?11:347.

53. Corona G, Petrone L, Mannucci et al: Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple of sexual dysfunction.j Androl 2006;27:795.

54. McCABE M, Althof See, Assalian P et al: Psychological and Interpersons of Gender of Sexual Function and Dysfunction.J sex with 2010;7:327.

55. Jannini her, Isidore am, averse A al: wat is the eerste?10:2359.

56. Althof See, Buvat J, Gutkin SW et al: Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors.J sex with 2010;7:203.

57. Mulhall JP, Goldstein I, Bushmakin Ag et al: Validation of erection hardness score.j sex with 2007;4:1626.

58. Rosen RC, Cappelli JC, Smith MD et al: Development and evaluation of a shortened 5-point version of the international index for erectile function (Iief-5) as a diagnostic tool for erectile dysfunction.Ten J Impot Res 1999;11:319.

59. Rosen RC, Riley A, Wagner G et al: The International Index for Erectile Function (Iief): a multidimensional scale for assessing erectile dysfunction.urology 1997;49:822.

60. Cappelery JC, Rosen RC, Smith MD et al: Diagnostic evaluation of the domain of the erectile function for the international index of erectile function.Ourology 1999;54:346.

61. Rosen RC, Allen KR, Ni X et al: At least clinically important differences in the domain of the erectile function for the international index for erectile function scales.EUR Urol 2011;60:1010.

62. Rosen RC, Catania J, Pollack L et al: Mandic Sexual Health Survey (MSHQ): Development of scale and psychometric validation.urology 2004;64:777.

63. Rosen RC, Catania JA, Althof See et al: Development and validation of the four-art-art version of male sexual health questionnaire to assess ejacul*tory dysfunction.urology 2007;69:805.

64. Dong JY, Zhang YH and Qin LQ: ERECTION DISCOUNTS AND RISK OF CARE FREEE CONDITIONS: Metaa analysis of partial cohort suggestions.j am Coll Cardiol 2011;58:1378.

65. Vlachopoulos CV, Derents-Printzios DG, Ioakeimidis NK et al: forecast of cardiovascular events and mortality for every reasons with erectile dysfunction: a systematic review and meta-analysis of cohort studies.Circ cardiovasca Qual has been followed 2013;6:99.

66. Thompson im, Tangen CM, Goodman PJ et al: erectile dysfunction and subsequent heart -cart -sickness.jama 2005;294:2996.

67. Montorsi P, Ravagnani PM, Galli s et al: Association between erectile dysfunction and coronary arteries.27:2632.

68. Hotaling JM, Walsh TJ, MacLeod Lc et al: Erectile dysfunction is not independent with heart -ssel -death: data of vitamins and lifestyle survey.j sex with 2012;9:2104.

69. Nehra A, Jackson G, Miner M et al: Princeton III -Consensus recommendations for dealing with erectile dysfunction and heart -car symphph.Mayo CLIN PROC 2012;87:766.

70. Hippisley-COX J, Coupland C and Brindle P: Development and validation of QRisk3 Risk formational algorithms to estimate the future risk of cardiovascular disease: potential cohort study.BMJ 2017;357:099.

71. Dahabgheh IJ and Paul JK: Association of Episodic physical and sexual activity with the creation of acute heart events: systematic review and meta analysis.Jama 2011;305:1225.

72. Wu FC, Tajar A, Beynon JM et al: Identification of Late-Begin Hypogonadism in middle-aged and older men.N Engl J with 2010;363:123.

73. Brambilla DJ, O'Donnell AB, Matsumoto am et al: Intrainadivuel variation in levels of serum testosterone and other reproductive and adrenal hormones in men.Clin Endocrinol (Oxf) 2007;67:853.

74. Brambilla DJ, Matsumoto AM, Araujo Ab et al: The effect of daily variation on clinical measurement of serum testosterone and other sex hormone levels in men.J Clin Endocrinol Metab 2009;94:907.

75. Welliver RC, Jr., Wiser HJ, Brannigan Re et al: The validity of the total testosterone levels in older men with erectile dysfunction.J Urol 2014;192:165.

76. WOOLF PD, Hamill RW, McDonald JV et al: transient hypogonadotropic hypogonadism caused by critical illness.J Clin Endocrinol Metab 1985;60:444.

77. Birthi P, Nagar VR, Nickerson r et al: Hypogonadism associated with long -term opioid treatment: a systematic review.J Opioid Manag 2015;11:255.

78. ELHABLY S and Elkholy A: Nocturnal Penile Erections: Rigiscan role in diagnosis of vascular erectile dysfunction.J sex with 2012;9:3219.

79. Jannni et al, Granata am, Hatzimouratidis K et al: Use and abuse of rigiscan in the diagnoses of erectile dysfunction.J sex with 2009;6:1820.

80. Sikka SC, Hellstrom WJ, Brock G et al: standardization of vascular assessment of erectile dysfunction: standard operational procedures for duplex -ultrasyd.j sex with 2013;10:120.

81. Vruggink PA, Diemont WL, Debruyne FM et al: Improved pharmacological test in patients with erectile dysfunction.J Androl 1995;16:163.

82. Dederik W, step CG, Lue TF et al: sympathetic inhibition of erection induced by Papavirin.J UROL 1991;146:195.

83. Elhably S, Schoor R, Elmogy M et al: Die is not -answered to the injection of Intrakaverø really indicates: a provision of quantitative analysis.J Urol 2002;167:192.

84. Lehmann K, John H, Kacl G et al: Variable response to intracavernous prostaglandin E1 test for erectile dysfunction.urology 1999;54:539.

85. Souper R, Hartmann J, Alvarez with Al: correlation between the maximum systolic speed and diameter of caves in the cave in weak versus dynamic state for evaluation of erectile dysfunction.Ten J Impot Res 2017;29:132.

86. Papagiannopoulos D, Khare N and Nehra A: Evaluation of young men with organic erectile dysfunction.asian J Androl 2015;17:11.

87. Ioakeimidis N, Vlachopoulos C, Rokkas K et al: Dynamic systolic speed for Penile -Peak predicts important side effects of heart vessels in hypertensive patients with erectile dysfunction.J Hypertens 2016;34:860.

88. Spiliopoulos S, Shaida N, Katsanos K et al: The role of intervention radiology in the diagnosis and handling of male impotence.Cardiovascian Internal Radio 2013;36:1204.

89. Giuliano F and Rowland DL: Standard operational procedures for neurophysiological assessment of male sexual dysfunction.j sex with 2013;10:1205.

90. Banner LL and Anderson RU: Integrated Sildenafil and Cognitive Behavior Sex Therapy for Psychogenic Erectding Disorders: a pilot survey.j Sex with 2007;4:1117.

91. Melnik T, ABDO CH, De Moraes JF et al: Satisfaction with the treatment, trust and 'naturalness' to participate in sexual activity in men with psychogenic erectile dysfunction: preliminary results of a randomized controlled study of three therapeutic approaches.2012;109:1213.

92. Titta M, Tavolini im, Dal Moro f et al: Sexual advice improved erectile rehabilitation after non-nervous radical retropubic prostatectomy or cystectomieres results from a randomized prospective study.J Gender with 2006;3:267.

93. Wylie KR, Jones RH and Walters S: The potential advantage of vacuum devices that increase psychosexual therapy to erectile dysfunction: a randomized controlled experiment.J Sex Marital Ther 2003;29:227.

94. MCCABE MP, Price E, Piterman L et al: Evaluation of a psychological intervention based on the internet for the treatment of erectile dysfunction.Int J Impot Res 2008;20:324.

95. Van Lankveld JJ, Leusink P, Van Diest s et al: Short sex therapy based on the internet for heterosexual men with sexual dysfunction: a randomized controlled pilot -experiment.j sex with 2009;6:2224.

96. Andersson e, Walen C, Hallberg J et al: A randomized controlled experiment with assisted internet -Contributed cognitive behavioral therapy for erectile dysfunction.J Sex with 2011;8:2800.

97.MeMnik T, Soares BG and Nasello AG: the effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons with Sildenafil treatment, Intracaernosal injection and vacuum decorations.J sex with 2008;5:2562. 98. Chambers SK, Occhipinti S, Schover L et al: A randomized controlled experiment with a few -based sexuality intervention for men with local prostate cancer and their female partners.Psychooncology 2015;24:748.

99. Ljunggren C and Stroberg P: Improvement of sexual function after robot assistant Radical prostatectomy: a rehabilitation program involving a clinical sexologist.Center European J Urol 2015;68:214.

100. Esposito K, Giugliano F, Di Palo C et al: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled test.Jama 2004;291:2978.

103. Collins CE, Jensen Me, Young MD et al: Improvement of the erectile function after weight loss in obescribed men: Shed-it randomized checked experiment.obes res clin Pract 2013;7:E450.

104. Khoo J, Piantadosi C, Wormley s et al: Effects of a little energy on sexual function and lower urinary tract symptoms in obescribed men.Int J Obes (Lond) 2010;34:1396.

105. Khoo J, Tian HH, Tan B et al: Comparison of the effects of low and high-volume-based intensity exercises on sexual function and testosterone in overweight men.J sex with 2013;10:1823.

106. Wing RR, Rosen RC, Fava Jl et al: Effects of intervention of weight loss on the erectile function in older men with type 2 diabetes in appearance.J sex with 2010;7:156.

107. Lamina S, Okoye CG and Dagogo TT: Therapeutic effect of an interval exercise education program for dealing with erectile dysfunction in hypertensive patients.J Clin Hypertens (Greenwich) 2009;11:125.

108. Begot I, Peixoto TC, Gonzaga Lr et al: A home -based walking program improves erectile dysfunction in men with an acute myocardinfarct.am J Cardiol 2015;115:571.

109. Kalka D, Domagala Z, Dworak J et al: Connection between physical exercise and quality of erection in men with ischemic heart conditions and erectile dysfunction exposed to physical exercise.Cardiolpool 2013;71:573.

110. Kalka D, Domagala ZA, Kowalewski p et al: Effect of endurance cardiovascular training intensity of severity of erectile dysfunction in men with ischemic heart disease.Am J Mens Health 2015;9:360.

111. KOVAC JR, Black C, Ramasamy r et al: Effects of smoking cigarettes on erectile dysfunction.UPDrologia 2015;47:1087.

112. AFIF-ABDO J, TELAKEN C, Damiao r et al: Comparative intersection study of Sildenafil and Apomorphine for the treatment of erectile dysfunction.bju int 2008;102:829.

113. Ali ST: Efficiency of Sildenafilcitrate (Viagra®) and Tadalafil (Cialis®) about sexual reactions in Saudi men with erectile dysfunction in routine clinical practice.Pack J Pharm SCI 2008;21:275.

114. Althof SE, O'Leary M P, Cappelli JC et al: Sildenafil Citrate improves self -confidence, trust and relationships in men with erectile dysfunction: results of an international, multicenter, double -blind, placebo -controlled test.2006;3:521.

115. BAI WJ, Li HJ, DAI YT et al: An open label, multicenter, randomized, crossover study in which Sildenafil-Citrate and Tadalafil compared to the treatment of erectile dysfunction in Chinese men naive with phosphodiesterase 5 inhibitors.17:61.

116. Bai WJ, Li HJ, JJ JJ et al: A randomized clinical study investigating the treatment choice among Chinese men who receive Sildenafil -Citrate and Tadalafil for the treatment of erectile dysfunction.asian J Androl 2016;

117. Bazaar M, Tekdogan Uy, Yilmaz et al: The effectiveness of herring file in various ethiology of erectile dysfunction.Tint Urol Nephrol 2001;32:403.

118. Becher E, Tejada Noriega A, Gomez R et al: sildenafil citrate (viagra) in the treatment of men with erectile dysfunction in southern Latin America: a double blind, randomized, placebo-controlled, parallel group, multicenter, flexible-dose Escalatiestudie.Int J impot res 2002;14 Suppl 2:Hav.

119. Belkoff LH, McCullough A, Goldstein in et al: an open clear, long -term evaluation of safety, efficiency and tolerability of Advvanafil in male patients with mild to serious erectile disorders.Thin J Clin Pract 2013;67:333.

120. Benard f, Carrier S, Lee Jc et al: Men with mild erectile dysfunction attracts the benefit of sildenafil -treatment.J Sex with 2010;7:3725.

121. Benchmroun A, Faik M, Benjelloun s et al: A baseline-controlled, open clear, flexible dose scale study to assess the safety and effectiveness of sildenafilcitrate (Viagra) (Viagra) in patients with erectile disorders.Thin J Impot Res 2003;15 Suppl 1:S19.

122. Boddi V, Castellini G, Casal H et al: An integrated approach with Vardenafil Orodispersible tablet and cognitive behavior Sex therapy to treat erectile dysfunction: a randomized controlled pilot research.Andrology 2015;3:909.

123. Brock G, Carrier S, Alarie P et al: The effect of doctor and patient education in combination with Vardenafil treatment in Canadian men with erectile dysfunction: an open clear, factor designed, cluster-randomized clinical test.j sex with 2008;5:705.

124. Brock GB, McMahon CG, Chen KK et al: Efficiency and safety of Tadalafil for the treatment of erectile dysfunction: results of integrated analyzes.j Urol 2002;168:1332.

125. Buvat J, Hatzichristou D, Maggi M et al: Efficiency, tolerance and satisfaction with Sildenafil Citrate 100 mg Titration compared to the continuous dose treatment of 50 mg in men with erectile disorders.bju int 2008;102:1645.

126. Buvat J, Buttner H, Hatzimouratidis K et2013;10:1592.

127. Hatzimouratidis K, Buvat J, buttner H et alint J Impot Res 2014;26:223.

128. Buvat J, Hatzichristou D, Boess FG et al: Continuation and efficiency of Tadalafil once a day during an observation study of 6 months in erectile dysfunction: edate survey.thin J Clin Pract 2014;68:1087.

129. Carrier S, Brock G, Casey r et al: Treatment satisfaction with Sildenafil in a Canadian reality.4:1414.

130. Carrier S, Brock GB, Pommerville PJ et al: Efficiency and safety of oral Tadalafil In the treatment of men in Canada with erectile dysfunction: a randomized, double blind, parallel, placebo -controlled clinical test.j sex with 2005;2:685.

131. Carson C, Shabsight, Segal s et al: Efficiency, security and treatment satisfaction of Tadalafil versus placebo in patients with erectile dysfunction evaluated by academic centers.Ourology 2005;65:353.

132. Carson CC, Rajfer J, Eardley in et al: The effectiveness and safety of Tadalafil: an update.bju int 2004;93:1276.

133. Chen KK, HSIEH JT, Huang St et al: Evaluation-3: A randomized, double blind, flexible dose of clinical examination of the effectiveness and safety of oral sildenafil in the treatment of men with erectile disorders in Taiwan.int j in 2001;13:221.

134. Chen KK, Jiann BP, Lin JS et al: Efficiency and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double blind, parallel, placebo-controlled clinical examination.2004;1:201.

135. Cheng e: Vardenafil's real life and effectiveness in the treatment of erectile dysfunction results of 30,010 US patients.J sex with 2007;4:432.

136. Choi HK, AHN TY, KIM JJ et al: a double blind, randomized placebo, controlled, parallel group, multicenter, flexible dose shifting study to assess the effectiveness and safety of sildenafil admitted as required for male outpatient spatients with ero -jurea.Int J Impot Res 2003;15:80.

137. Choi HK, Kim JJ, Kim sc et al: A randomized, double blind, parallel, placebo-controlled study of the effectiveness and safety of Tadalafil that is administered on-demand for men with erectile disorders in Korea.korean J Urol 2006;47:852.

138. Christiansen E, Guirguis WR, Cox D et al: Long -term efficiency and safety of Oral Viagra (Sildenafilcitrate) in men with erectile dysfunction and the effect of randomized treatment extraction.Int -Jume Impot Res 2000;12:177.

139. Costa P, Buvat J, Holmes s et al: Predictors for Tadalafil -Efficiency in men with erectile dysfunction: the safe study compared to two dosing regimes.J sex with 2006;3:1050.

140. Mirone V, Costa P, Damber you et al: An evaluation of an alternative dosing regime with Tadalafil, 3 times/week, for men with erectile dysfunction: safe research in 14 European countries.EUR Urol 2005;47:846.

141. Costa P, Grand Mote G, Mai HD et al: Effect of a first treatment with phosphodiesteraser inhibitors about the quality of the sexual life of men and partners: results of a prospective study in primary care.J sex with 2013;10:1850.

142. Dean J, Hackett Gi, Gentile V et al: Psychosocial results and drug attributes that influence the treatment choices in men who receive sildenafil-citrate and tadalafil for the treatment of erectile dysfunction: results of a multi-center, randomized, open label, crossover-study.J sex with 2006;3:650.

143. Eardley I, Mirone V, Montorsi f all: an open clear, multicenter, randomized, crossover study in which Sildenafil-Citrate and Tadalafil are compared with the treatment of erectile dysfunction in men naive with phosphodiesterase 5-inhibitors;96:1323.

144. Dinsmore WW, Hodges M, Hargreaves C et al: Sildenafil -Citraat (Viagra) in erectile dysfunction: almost standardization in men with the broad spectrum erectile dysfunction compared to age -healthy health control persons.urology 1999;53:800.

145. Donatucci C, Eardley I, Buvat J et al: Vardenafil improves the erectile function in men with erectile dysfunction, regardless of the diploma and disease classification.J sex with 2004;1:301.

146. Eardley I, Gentile V, Austoni e al: Efficiency and safety of Tadalafil in a Western European population of men with erectile dysfunction.Bju int 2004;94:871.

147. Eardley I, Morgan R, Dinsmore W et al: Efficiency and safety of sildenafilcitrate in the treatment of men with mild to moderate erectile dysfunction.Br J Psychiatry 2001;178:325.

148. Eardley I, Wright P, Macdonagh r et al: An open clear, randomized, flexible dose, crossover study to assess the comparative efficiency and safety of sildenafil-citrate and apomorphine hydrochloride in men with erection disorders.Bju int 2004;93:1271.

149. Edwards D, Hackett G, Collins O et al: Vardenafil improves sexual function and treatment satisfaction in pairs that are influenced by erectile dysfunction (ED): a randomized, double blind, placebo-controlled tests in PDE5 inhibitors-naive men with Oathsand partners .j sex with 2006;3:1028.

150. El Khiat Y, Ghazis, Allam a et al: Psychosocial influence and efficiency of Tadalafil in treatment of treatment and previously treated men with erectile dysfunction in Saudi Arabia and other countries in the Gulf region.Curr with res opinion 2008;24:1965.

151. fa*gelman E, fa*gelman A and Shapsde R: Efficiency, safety and use of Sildenafil in Urological Practice.urology 2001;57:1141.

152. Zonana Farca E, Francolugo-relez V, Moy-eransus c et al: self-respect, trust and relationship satisfaction in men with erectile dysfunction: a randomized, parallel group, double-blind, placebo-controlled study of Sildenafil Imexico.Int J Impot Res 2008;20:402.

153.2:699.

154. Goldstein I, Fisher Wa, Sand M et al: The sexual function of women has improved when partners are administered to erectile dysfunction: a prospective, randomized, double blind, placebo -controlled test.j sex with 2005;2:819.

155. Fugl-Meyer KS, Stotard D, Beger M it al.int J Clin Pract 2006;60:1386.

156. Fujisawa M and Sawada K: Clinical efficiency and security of sildenafil in older patients with erectile dysfunction.Arch Androl 2004;50:255.

157. Giammusso B, Colpi GM, Cormio L et al: An open clear, randomized, flexible dose, crossover study to assess the comparative efficiency and safety of sildenafilcitrate and Apomorpho -hydrochloride in men with erection disorders;81:409.

158. Gil a, Martinez e, Oyaguez in et al: erectile dysfunction in primary care: results of an observational, non-control group, prospective study with sildenafil under routine conditions of use.13:338.

159. Gittelman M, McMahon CG, Rodriguez-Rivera Yes et al: The Potent II Randomized study: Efficiency and safety of an orodisheric Varmens-Oil formulation for the treatment of erection disorders.Thin J Clin Pract 2010;64:594.

160. Giuliano F, Donatucci C, Montorsi f Al: Vardenafil is effective and is well tolerated for the treatment of erectile dysfunction at a broad population of men, regardless of age.Bju int 2005;95:110.

161. Giuliano F, Montorsi F, Mirone V et al: Shift from Intracaernous Prostaglandine E1 injections to oral Sildenafil -Citrate in patients with erectile dysfunction: results of a European study from multicenter.164:708.

162. Glina S, Bertero E, Claro J et al: Efficiency and safety of flexible dose of oral sildenafilcitrate (Viagra) in the treatment of erectile dysfunction with Brazilian and Mexican men.14 Suppl 2:Hoot.

163. Glina S, Damiao R, ABDO C et al: Self-respect, trust and circ*mstances among Brazilian men with erectile dysfunction who receive Sildenafil citrate: a randomized, parallel group, double blind, placebo-controlled study in Brazil.j sex with 2009;6:268.

164. Cairoli C, Reyes La, Henneges C et al: PDE5 inhibitor treatment Portage and attachment among Brazilian men: post-hoc analyzes of a 6-month, prospective observation study.In Braz J Urol 2014;40:390.

165. Gokce Mi, Gulpinar O, Ozturk e et al: Estervastatin effect on erectile functions compared to regular tadalafil use.44:683.

166. Goldstein I, Kim E, sends WD et al: Efficiency and safety of Tadalafil in men with erectile dysfunction with a high incidence of comorbide modes: results of Momentus: more observations in men with erectile dysfunction in national tadalafil study in the United States in the United StatesStates in the United States in the United States in the United States in the United States in the United States in the United States in the United States in the United States.4:166.

167. Goldstein I, McCullough AR, Jones La et al: A randomized, double blind, placebo -controlled evaluation of the safety and effectiveness of Avanafil in people with erectile dysfunction.J sex with 2012;9:1122.

168. Goldstein I, Lue TF, Padma-Nathan H et al: Oral Sildenafil in the treatment of erectile dysfunction.Sildenafil Study Group.n Engl J with 1998;338:1397.

169. Goldstein I, Teng LJ, Creananga D et al: Efficiency and safety of sildenafil due to age in men with erectile dysfunction.J sex with 2016;13:852.

170. Gomez F, Davila H, Costa a et al: Efficiency and safety of oral sildenafilcitrate (Viagra) in the treatment of male erectile dysfunction in Colombia, Ecuador and Venezuela: a double blind, multicenter, placebocrun 2002;14 Suppl 2:S42.

171. Govier F, Potempa AJ, Kaufman J et al: a multicenter, randomized, double-blind, crossover study of the patient's preference for tadalafil 20 mg or sildenafilcitrate 50 mg when initiating the treatment of ero-dysfunction.clin Ther 2003;25:2709.

172. Guo Yl, Zhu JC, Pan tm et al: Efficiency and safety of on-demand Tadalafil for the treatment of erectile dysfunction in Southeast Asian men.In J Urol 2006;13:721.

173. Hartmann U, Hanisch Ju and Matterntern A: The real perception of efficiency, attitude, satisfaction and safety of Vardenafil therapy (repetition): a potential, non-interventional, observational research.17:117.

174. Hatzichristou D, Cuzin B, Martin-Morales a et al: Vardenafil improves satisfaction, depressive symptomatology and trust in a broad population of men with erectile dysfunction.J sex with 2005;2:109.

175. Hatzichristou D, Montorsi F, Buvat J et al: The effectiveness and safety of flexible dose of Varden (Levitra) in a broad population of European men.EUR Urol 2004;45:634.

176. Hatzichristou D, Vardi Y, Papp g et al: Effect of Tadalafil on patterns of sexual timing in men with erectile dysfunction: integrated analysis of randomized, placebo -controlled studies.J Urol 2005;174:1356.

177. Heiman JR,114:437.

178. Hellstrom WJ, Gittelman M, Karlin G et al: Vardenafil For the treatment of men with erectile dysfunction: efficiency and safety in a randomized, double blind, placebo -controlled test.j Androl 2002;23:763.

179. Hellstrom WJ, Gittelman M, Karlin G An Alpivotal Litigation.urology 2003;61:8.

180. Huang ST: use sildenafil -citrate to treat Taiwanese men with erectile dysfunction: a single centrumer experience.Chng Gung with J 2001;24:91.

181. Hundertark J, Esernman A, Ben-Tovim D et al: The South Australian couples of Sildenafil survey: double-blind, parallel group Randomized controlled study to use the psychological and relationship-effects of sildenafil use in Par.j sex with 2007 te teto research ;4:1126.

182. Isidori am, Corona G, Aversa a et al: Siams-ed: a national, independent, multicentre study of cardiometabolic and hormonal weakening of men with erectile dysfunction treated with Vandafil.int j endocrinol 2014;2014:doi: 10.1155/2014/858715.

183. Jamshidian H, Borhan A, Kooraki s et al. There is a cumulative effect?62:1195.

184. Jannini et al., Isidori am, Gravina Gl et al: endotrial examination: a spontaneous, open label, randomized multicenter, crossover examination into the efficiency of sildenafil, tadalafil and vandura-piling in the treatment of ero-disorders.6:2547.

185. Jarow JP, Burnett Al and Ginger am: Clinical efficiency of sildenafilcitrate based on ethiology and response to earlier treatment.J Urol 1999;162:722.

186. Jarvi K, Dula E, Drehobl m et al: Daily Varenafil For 6 months has no harmful effects on sperm characteristics or reproductive hormones in men with normal basic levels.J Urol 2008;179:1060.

187. Jiann BP, Yu CC, Tsai Jy et al: What to learn about Sildenafil in the treatment of erectile dysfunction from 3-year-old clinical experience.Thin J Impot Res 2003;15:412.

188. Jones La, Klimberg IW, McMurray JG et al: Effect of Sildenafil-Citrate on the male sexual experience rated with the sexual experience questionnaire: a multicenter, double blind, placebo-controlled test with open label extension.j sex with 2008;5:1955.

189. Kadioglu a, Grohmann W, Depko a et al: Quality of erections in men treated with flexible dose of sildenafil for erectile dysfunction: multicenter experiment with a double -blind, randomized, placebo -controlled phase and a open phase.with 2008;5:726.

190. Kamalov AA, Dorofeev SD, Egov et al: The Russian experience of studying Vardenafil -Efficiency and safety in men with erectile dysfunction of different etiologies.5:36.

191. Camel A, Khaouli R, Sabha M et al: Vardenafil's real life and efficiency: an international study after marketing of 2824 patients from the East.Clin Drug Investig 2007;27:339.

192. Kang DH, Lee You, Park are et alkoreansk J Urol 2010;51:647.

193. Kang DH, Lee JY, Chung Jh et al: Comparison of the efficiency for erectile function and lower urinary tract symptoms on Tadalafil 20 mg on-demand and 5 mg once a day in patients with erectile dysfunction.In J Clin Pract 2012;66:813.

194. Kim E, Seftel A, Goldfischer e et al: Efficiency of the axis needs PDE5 brake therapy vs.tadalafil once a day by improving erectile dysfunction.J sex with 2014;11: 176.

195. Seftel Ad, Rosen RC, Hayes RP et al: Effect of Tadalafil once a day for trust and observed difficulties in performing sexual sexual intercourse among men who were incomplete respondents on the AS-Neded PDE5 inhibitor treatment.In J Clin Pract 2014;68:841.

196. Kim E, Seftel A, Goldfischer e et al: Comparative efficiency of Tadalafil once a day in men with erectile dysfunction, which shows earlier partial reactions to Sildenafil, Tadalafil or Vardenafil.curr with Res Menpection 2015;31:379.

197. Burns PR, Rose RC, Dunn M et al.j Sex With 2015;12:720.

198. Kim CM, KIM YS, Sunwoo in Al: Research study after marketing of the efficiency and safety of Varmens in patients with erectile dysfunction in primary care.The J Impot Res 2007;19:393.

199. Kirby M, Creananga DL and Stecher VJ: Erectile function, erection hardness and tolerance in men treated with sildenafil 100 mg vs.50 mg for erectile dysfunction. Int J Clin Pract 2013;67:1034.

200. Kobayashi K, Hisasue S, Kato r et al: Result analysis of Sildenafil -Citrate for erectile dysfunction of Japanese patients.18:302.

203. Kumar S, ROAT R, Agrawal s et al: Combination therapy from Tadalafil and Pentoxifylline in severe erectile dysfunction: a prospective randomized experiment.POL PRZEBL CHIR 2015;87:377.

204. Levinson IP, Khalaf IM, Shaeer KZ et al: Efficiency and safety of Sildenafil -Citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa.Int J Impot Res 2003;15 Suppl 1:Hed.

205. Lewis R, Bennett CJ, Borkon WD et al: Patient and partner satisfaction with Viagra (Sildenafil Citrate) Treatment as determined by erectile dysfunction Inventory of satisfaction questionnaire.urology 2001;57:960.

206. Li G, Lan H, Liang J et98:205.

207. GLUE PH, Li MK, NG FC et al: Clinical efficiency and safety of sildenafilcitrate (Viagra) in a multiracial population in Singapore: a retrospective study in 1520 patients.9:308.

208. Loran OB, Strobrerg P, Lee SW An Alamies Trial.J Sex With 2009;6:2826.

209. Magoha GA: Sildenafil (Viagra) in the treatment of erectile dysfunction in Nairobi.East AF with J 2000;77:76.

210. Marks LS, Duda C, Dorey FJ ​​et al: Treatment of erectile dysfunction with sildenafil.urology 1999;53:19.

211. Martin-Morales A, Graziottin A, Jaoude GB et al: Improvement of the sexual quality of life for the female partner after Vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.J Sex with 2011;8:2831.

212. Martin-Morales A, Gutierrez-Hernandez P, Romero-Overero J et al: Duration of erection: Does it really have something?The connection with the sexual quality of life of patients and partners and the duration of sexual intercourse: the Wadopen study.J sex with 2014;11:1527.

213. Martin-Morales A, Haro JM, Beardsworth a et al: Therapeutic efficiency and satisfaction of the patient after 6 months of treatment with Tadalafil, Sildenafil and Vardenafil: Results of erectile dysfunction Observation study (Edos).EUR Urol 2007;51:541.

214. Martin-Morales A, Meijide F, Garcia n et al: Efficiency of Vardenafil and influence on self-respect and trust in patients with severe erectile dysfunction.J sex with 2007;4:440.

215. Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort r et al: Prognostic factors for response to Sildenafil in patients with erectile dysfection.EUR UROL 2001;40:641.

216. McMahon CG, Samali R and Johnson H: Efficiency, Security and Acceptance by the patient of Sildenafilcitrate as treatment of erectile dysfunction.J UROL 2000;164:1192.

217. McMahon C, Clones RA, Hutter Jr Am An Alh Sex With 2005;2:415.

218. McMahon C, Lording D, Stuckey B et al: Vardenafil improved erectile function in a "real" wide population study of men with moderate to serious erectile dysfunction in Australia and New Zealand.J sex with 2006;3:892.

219. McMahon CG, Stuckey BG, Lording DW et al.int J Clin Pract 2005;59:143.

220. McMurray JG, Feldman RA, Auerbach SM et al: Long -term safety and efficiency of sildenafilcitrate in men with erectile dysfunction.Ther Clin Risk Manag 2007;3:975.

221. Meuleman E, Cuzin B, Opposer RJ et al: A dose scale study to assess the effectiveness and safety of sildenafil citrate in men with erectile dysfunction.Bju int 2001;87:75.

222. Mirone V, Palmieri A, Cucinotta D et al: Flexible dose of Vartafil In a socially-based population of men affected by erectile dysfunction: a 12-week open label, multicenter experiment.j sex with 2005;2:842.

223. Moncada I, Martinez-Jabaloyas JM, Rodriguez-Vela L et al: Emotional changes in men treated with Sildenafil Citrate for erectile dysfunction: a double-blind, placebo-controlled clinical investigation.J Sex with 2009;6:3469.

224. Montorsi F and Althof See: Partner's response to Sildenafil Citrate (Viagra) Treatment of erectile dysfunction.urology 2004;63:762.

225. Montorsi F, Aversa A, Moncada in et al: A randomized, double-blind, placebo-controlled, parallel study to assess the effectiveness and safety of Tadalafil once a day in men with erectile dysfunction Naive for PDE5 inhibitors.;8:2617.

226. Porst H, Brock GB, Kula K et33:1305.

227. Montorsi F, Hellstrom WJ, Valiquette L et al: Vardenafil offers reliable efficiency in time in men with erectile dysfunction.urology 2004;64:1187.

228. Montorsi F, McDermott Te, Morgan r et al: Efficiency and safety of a fixed dose of oral sildenafil in the treatment of erectile dysfunction of different etiologies.urology 1999;53:1011.

229. Montorsi F, Padma-Nathan H, Buvat J et al: The earliest time before entering action leads to successful sexual intercourse with Vandafil determined in a home environment: a randomized, double-blind, placebo-controlled sample.J Sex with 2004 with 2004 with 2004with 2004 with 2004;1:168.

230. Montorsi F, Verheyden B, Meuleman e et al: Safety and tolerance in the long term of Tadalafil in the treatment of erectile dysfunction.EUR Urol 2004;45:339.

231. Moreira SG, Jr., Brannigan Re, Spitz a et al: Side effect profile by Sildenafil Citrate (Viagra) in Clinical Practice.urology 2000;56:474.

232. Morning -Depenses A, Barada J, Niederberger C et al: Efficiency and safety of Tadalafil about ethnic groups and various risk factors in men with erectile dysfunction: use of a new non -information study design.j sex with 2006;3:492.

233. Gomery P, Bullock A, McGettenan J etInint.J Impot Res 2007;19:76.

234. Muller A, Smith L, Parker M et al: Analysis of the effectiveness and safety of Sildenafil -Citrate in the geriatric population.Bju int 2007;100:117.

235. Nagao K, She n, Kamidono s al: Security and efficiency of Valdenafil in patients with erectile dysfunction: result of a interruption test in Japan.The J Urol 2004;11:515.

236. Nagao K, Kimoto Y, Marumo K et al: Efficiency and safety of Tadalafil 5, 10 and 20 mg In Japanese men with erectile dysfunction: results of a multi -center, randomized, double blind, placebo -controlled study.urology 2006;68:845.

237. O'Leary MP, Althof SE, Cappelli JC et al: self-respect, self-confidence and relationship satisfaction for men with erectile dysfunction treated with Sildenafil Citrate: a multicenter, randomized, parallel group, double-blind, placebo-controlled study in the assistant2006;175:1058.

238. Ochiai A, Naya Y, Soh J et al: Efficiency of Sildenafil as the first step therapeutic aid for Japanese patients with erectile dysfunction.Tin J Impot res 2005;17:339.

239. Olsson am, Speakman MJ, Dinsmore WW et al: Sildenafil -Citraat (Viagra) is effective and is well tolerated for the treatment of erectile dysfunction of psychogenic or mixed etiology.54:561.

240. OSEGBE DN, sh*ttu Ob, Aghaji Ae et al: Sildenfile Citrate (Viagra) for the treatment of erectile dysfunction in Nigerian men.Int J IMPT result 2003;15 Suppl 1:S15.

241. Padma-Nathan H, McMurray JG, Pullman We et al: On-Demand IC351 (Cialis) improves the ero-rises in patients with erectile dysfunction.Int J Impot Res 2001;13:2.

242. Padma-Nathan H, Steers WD and Wicker PA: Efficiency and safety of oral sildenafil in the treatment of erectile dysfunction: a double blind, placebo-controlled study of 329 patients.52:375.

243. Palumbo F, Bettocchi C, Selvaggi FP et al: Sildenafil: Efficiency and security in daily clinical experience.EUR UROL 2001;40:176.

244. Pavone C, CURTO F, Anello GT Al: prospective, randomized crossover -comparison of sublingual apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction.j Urol 2004;172:2347.

245. PERIMENY P, Gyftopoulos K, Giannitsas K etTht J Impot res 2004;16:2.

246. Perimenis P, Markou S, Gyftopoulos K et al: Efficiency of apomorphine and sildenafil in men with non -artery erectile dysfunction.36:106.

247. Porst H, Behre HM, Jungwirth a et al: Comparative experiments with treatment satisfaction, efficiency and tolerance of sildenafil versus apomorphine in erectile dysfunction and open, randomized crossover study with flexible dosing.EUR J with RES 2007;12:61.

248. Porst H, GACCI M, Buttner H et: Tadalafil Once a day in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double blind, placebo -controlled, clinical studies.eur Urol 2014;65:455.

249. Porst H, Giuliano F, Glina s et al. Controlled Monster.EUR Urol 2006;50:351.

250. Porst H, Rajfer J, Casabe a et al: Safety and long -term safety and efficiency of Tadalafil 5 mg dose once a day in men with erectile dysfunction.J sex with 2008;5:2160.

253. Potempa AJ, Ulbrich E, Bernard in et al: Efficiency of Vardenafil In men with erectile dysfunction: a flexible dose-practice study.EUR Urol 2004;46:73.

254. Rajfer J, Aliotta PJ, Steider CP et al: Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double blind, placebo-controlled study in the US.TIN J Impot Rescence 2007;19:95.

255. Ralph D, Eardley I, Kell P et al: Improving the erectile function on Vardenafil treatment correlates with treatment satisfaction in both patients and their partners.Bju int 2007;100:130.

256. Rosen R, Janssen E, Wiegel M et al: Psychological and interpersonal correlates in men with erectile dysfunction and their partners: a pilot study of the treatment result with sildenafil.j sex Marital Ther 2006;32:215.

257. Rosenberg MT, Adams PL, McBride TA Ever Al: Improvement in the erection time after phosphodiesterase type 5 inhibitory therapy with vehicle in men with erectile dysfunction: the endurance study.Thin J Clin Pract 2009;63:27.

258. Roumeguere t, Verheyden B, inherits in the al: Therapeutic response after the first month of Tadalafil treatment predicts 12 months of treatment time in patients with erectile dysfunction: results of the detecting examination.j sex with 2008;5:1708.

259. Perimenis P, Roumeguere T, Heidler H et: Evaluation of the expectations of the patient and treatment satisfaction after 1 year Tadalafil therapy for erectile dysfunction: detection study.J sex with 2009;6:257.

260. Rubio-Aurioles E, Casabe A, Torres Lo et al: Efficiency and safety of Tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyzes.j sex with 2008;5:1965.

261. Rubio-Aurioles E, Kim Ed, Rosen RC et al: Influence of erectile function and sexual quality of life: a double-blind, randomized, placebo-controlled study by Tadalafil taken once a day.J sex with 2009;6:1314.

262. Seftel Ad, Buvat J, Althof See ever: Improvements in self -confidence, sexual relationship and satisfaction measures: Results of a randomized study by Tadalafil 5 mg once taken daily.21:240.

263. Rubio-Aurioles E, Porst H, Kim Ed An alerectile dysfunction.J Sex with 2012;9:1418.

1.Chatram K, Kulinskaya A, Anburi Da Ed Cry.Punch urom ௨௦௦௨;2:4.

265. Saylan M, Khalaf I, Kadioglu a et al: Efficiency of Tadadafil in Egypt and Turkish men with erectile dysfunction.60:812.

266. Seftel Ad, Creanga DL and Levinson IP: Sildenafil reduces the trouble associated with erectile dysfunction: overall analysis of five randomized, double blind examinations.19:584.

267. Seftel Ad, Wilson SK, Button PM et al: The effectiveness and safety of Tadalafil in the American and Puerto Rica men with erectile dysfunction.J Urol 2004;172:652.

268. Shabsight, Kaufman J, Magee M et al: a multicenter, double-blind, placebo-controlled attempt to assess the effectiveness of sildenafilcitrate in men in men with non-recognized erection disorders.urology 2010;76:373.

269. Shin ys, Lee SW, Park K etImpot Res 2015;27:95.

270. Skoumal R, Chen J, Kula K et al: Efficiency and treatment satisfaction with on-demand Tadalafil (Cialis) in men with erectile dysfunction.EUR Urol 2004;46:362.

271. Summer F, Klotz T and Engelmann U: Improved spontaneous erectile function in men with mild to moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for a year: a randomized experiment.Asian J Androl 2007;9:134.

272. SPERING H, Debruyne F, Boermans a et al: The powerful randomized experiment: efficiency and security of an orodisheri -fern formulation for the treatment of erectile dysfunction.J Sex with 2010;7:1497.

273. SPERING H, Schneider T and Hanisch Ju: Acceptance of therapy with patients treated with Vardenafil with erectile dysfunction (active): a non-interventional study in Germany.22:61.

274. Staab A, Tillmann C, Forget St et al: Population Dose Responses Model for Tadalafil in the treatment of male erectile dysfunction.Pharm Res 2004;21:1463.

275. Send W, Guay At, Leriche a et al: Assessment of the effectiveness and safety of Viagra (Sildenafil Citrate) in men with erectile dysfunction during long -term treatment.Tht J Impot Res 2001;13:261.

276. Steidle CP, McCullough AR, Fampingky JC et al: Early Sildenafil -Dose optimization and personal instruction improves frequency, flexibility and success with sexual condition in men with erectile dysfunction.Thin J Impot Res 2007;19:154.

277. Stief C, Porst H, Saenz de Tejada in et al: Persistent efficiency and tolerance with a vandafil for 2 years of treatment in men with erectile dysfunction.In J Clin Pract 2004;58:230.

278. Stroberg P, Murphy A and Costigan T: Change of patients with erectile dysfunction from sildenafilcitrate to Tadalafil: results of a European multicenter, open clear study of the patient's preference.Clin Ther 2003;25:2724.

279. Sunwoo s, Kim YS, Cho BL et al: Research study after marketing of the safety and effectiveness of Sildenafil, prescribed in first -line care for patients with erectile dysfunction.17:71.

280. Tan HM, Chin CM, Chua CB et al: Efficiency and tolerability of Varden in Asian men with erectile dysfunction.Asian J Androl 2008;10:495.

281. Tan HM, MOH CL, Mendoza JB et al: Asian Sildenafil Efficiency and Security Survey (assessment 1): a double blind, placebo-controlled, flexible dose oral sildenafil in Malaysian, Singaporic and Philippine.2000;56:635.

282. Tang WH, Zhuang XJ, MA LL et al: Effect of Sildenafil on erectile dysfunction and improving the quality of sexual life in China: a multicenter study.8:11539.

283. Taylor J, Baldo OB, Storey a et al: Differences in the duration of the side effect and related genen levels between phosphodiesterase type 5 inhibitors.Bju int 2009;103:1392.

284. Tolera jr, Campana JM, City LF et alj Sex with 2006;3:901.

285. Tsujimura A, Yamanaka M, Takahashi T et al: The Clinical Studies of Sildenafil Voor de Verouderende Man.Int J Androl 2002;25:28.

286. Valiquette L, Montorsi F and Auerbach S: Vardenafil shows the success and reliability of the first dose and reliability of penetration and maintenance of erection in men with erectile dysfunction of ii.can Urol Assoc J 2008;2:187.

287. Valiquette L, Young JM, Moncada in et al: Persistent efficiency and safety of Varden for treatment of erectile dysfunction: a randomized, double blind, placebo -controlled research.Mayo Clin ProC 2005;80:1291.

288. Van Ahlen H, Zumbe J, Stauch K et al: The real lifelong safety and efficiency of Vardenafil (realized) study: results in men from Europe and abroad with erecti disorders and cardiovascular or metabolic conditions.J sex with 2010;7:3161.

289. Virag R: Indications and early results of Sildenafil (Viagra) in erectile dysfunction.urology 1999;54:1073.

290. Von Kez A, Rajfer J, Segal s et al: a multicenter, randomized, double blind, crossover study to evaluate the patient's preference between Tadalafil and Sildenafil.eur Urol 2004;45:499.

291. Wagner G, Montorsi F, Auerbach s et al: Sildenafil Citrate (Viagra) improves the erectile function in older patients with erectile dysfunction: a subgroup analysis.j gerontol a organic sci with sci 2001;56:M 113.

292. Wijitsetettakul U and Pempongkosol S: the efficiency and safety of on-demand Elonza;A generic product from Sildenafil among Thai men with erectile dysfunction.J with Assoc Thai 2013;96:683.

293. Yang Y, Liu R, Jiang H et: Association between dosing frequency and the treatment results of Sildenafil in young and medium -sized men with erectile dysfunction: a Chinese multicenter, observation study.urology 2015;86:62.

294. YIP WC, Chiang HS, Mendoza JB Ever Al: Efficiency and safety for sought-after Tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double blind, parallel, placebo-controlled clinical exam.2006;8:685.

295. Young JM, Bennett C, Gilhooly P et al: Efficiency and safety of Sildenafil Citrate (Viagra) in Black and Latin -American Men.urology 2002;60:39.

296. Zhang K, XU B, Liu D et al: Sildenafil improves erectile hardness in Chinese men with erectile dysfunction: a reality study analyzed by Age Stratification.urology 2014;83:831.

297. ZHAO C, KIM SW, Yang Dy et al: Efficiency and safety of Avanafil For the treatment of erectile dysfunction: results of a multi -center, randomized, double blind, placebo -controlled test.bju int 2012;110:1801.

298. Zumbe J, Port H, Summer F et al: Similar efficiency of once a day versus on-demand Varteafil in men with mild to moderate erectile dysfunction: finding the recovery study.EUR Urol 2008;54:204.

299. Park HJ, Kim SW, Kim JJ et al: A randomized, placebo -controlled, double blind, multicentic positive study to evaluate the safety and effectiveness of Avanafil in Korean patients with erectile disorders.Jorean with SCI 2017;32:1016.

300. Li HJ, Bai WJ, Dai Yte ever: An analysis of treatment preferences and sexual quality of life results in female partners of Chinese men with erectile dysfunction.Asian J Androl 2016;18:773.

301. BAI WJ, Li HJ, JJ JJ et al: A randomized clinical study investigating the treatment choice among Chinese men who receive Sildenafil -Citraat and Tadalafil for the treatment of erectile dysfunction.Asian J Androl 2017;19:500.

302. MASTERDODO P, Ventimiglia e, Boeri l et Alekspert Rev Clin Pharmacol 2017;10:339.

303. Karabakan M, Keskin E, Akdemir s et al: Effect of Tadalafil 5 mg Daily treatment on ejacul*tion times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction.Int Braz J Urol 2017;43:317.

304. Gong B, Mon M, Xie W et al: Direct comparison of Tadalafil with Sildenafil to treat erectile dysfunction: a systematic review and meta analysis.Tint Urol Nephrol 2017;49: 1731.

305. Bekkering GE, Abou-Setta AM and Kleijnen J: Use of quantitative methods for identifying and examining the presence of bias in systematic assessments: PDE-5 inhibitors to erectile dysfunction.Thin J Impot Res 2008;20:264.

306. BERNER MM, Kriston L and damage A: Efficiency of PDE-5 inhibitors for erectile dysfunction.A comparative meta-analysis of randomized fixed dose regime randomized controlled experiments that manage the international index for the erectile function in wide-spectrumpopulations.18:229.

307. Chen L, Staubli SE, Schneider MP et al: Phosphodiesterase 5 inhibitors to treat erectile dysfunction: a meta-analysis of compromiseetwork.eur Urol 2015;68:674.

308. Tssertvadze A, Fink Ha, Yazdi f al: Oral phosphodiesterase-5 inhibitors and hormone treatments for erectile dysfunction: a systematic review and meta-analysis.An internal with 2009;151:650.

309. Tsertvadze A, Yazdi F, Fink Ha Ever Al: Oral Sildenafil Citrate (Viagra) to erectile dysfunction: a systematic review and meta analysis of damage.urology 2009;74:831.

310. Yuan J, Zhang R, Yang z et al: Comparative efficiency and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta analysis.EUR UROL 2013;63:902.

311118:60.

312. Burls A, Gold L and Clark W: Systematic review of randomized controlled studies of Sildenafil (Viagra) in the treatment of male erectile dysfunction.Br J Gen Pract 2001;51:1004.

313. Fink Ha, Mac Donald R, Rutks Ir et al: Sildenafil for male erectile dysfunction: a systematic review and meta analysis.Arch internally with 2002;162:1349.

314. Kriston L, Harms A and Bernese MM: A meta-recession analysis of treatment modifications in tests with flexible dose of oral sildenafil to erectile dysfunction in the broad spectrum.Thin J Impot res 2006;18:559.

315. Moore RA, Edwards Je and Mcquay HJ: Sildenafil (Viagra) to male erectile dysfunction: a meta analysis of clinical experimental reports.bmc Urol 2002;2:6.

316. Money Z, Yang L, Dong Q et al: Efficiency and safety of Tadalafil once a day against Tadalafil On-Demand in patients with erectile dysfunction: a systematic review and meta-alyses.urol int 2017;99: 343.

317. Markou S, Perimenis P, Gyftopoulos K et al: Vardenafil (Levitra) to erectile dysfunction: a systematic review and meta analysis of clinical experimental report.Thin J Impot res 2004;16:470.

318. Cui ys, Li N, sang HT et al: Avanafil for male erectile dysfunction: a systematic review and meta -analysis.asian J Androl 2014;16:472.

319. Wang H, Yuan J, HU X et al: The efficiency and security of Avanafil for erectile dysfunction: a systematic review and meta analysis.Curr with res Opin 2014;30:1565.

320. Behrend L, Vibe-Pernes J and Perrild H: Sildenafil in the treatment of erectile dysfunction in men with diabetes: demand, efficiency and satisfaction of the patient.17:264.

321. Blond L: Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of total data from placebo-controlled studies.Curr with res Opin 2006;22:2111.

322. Boulton AJ, SELAM JL, SEENEY MT AL: SILDENAFIL -Citrate for the treatment of erectile dysfunction in men with diabetes mellitus type 2. Diabetologia 2001;44:1296.

323. Burnett Al, Strong TD, Trock BJ et al: Serumbiomarker -Measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.J Urol 2009;181:245.

324. Buvat J, Van Ahlen H, Schmitt H et al: Efficiency and safety for two dosing regimes from Tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: planned use against the on-demand regime evaluation (safe) study in 14European countries.J sex with 2006;3:512.

325. Chen Y, CUI S, Lin H et: Losartan improves erectile dysfunction in diabetes patients: a clinical study.Tht J Impot Res 2012;24:217.

326. Deyong L, Chung E, Kovac Jr et al: Daily use of Sildenafil improves the endothelial function in men with type 2 diabetes.j Androl 2012;33:176.

327. El-Sakka AI: Efficiency of sildenafilcitrate in the treatment of erectile dysfunction: effect of type 2 diabetes.EUR Urol 2004;46:503.

328. El-Sakka Ai, Anis T, Khadr n et al: Sildenafil to erectile dysfunction in the Middle East: Observation analysis of patients with diabetes and/or hypertension treated in the setting of clinical practice.39:558.

329. Fonseca V, Seftel A, This J et al: Effect of diabetes mellitus on the severity of erectile dysfunction and response to processing: analysis of data from Tadalafil Clinical Trial ..Iabologia 2004;47:1914.

330. Gentile V, Vicini P, Prigiotti G et al: Provisional observations about the use of Propionyl-L-Carnitine in combination with Sildenafil in patients with erectile dysfunction and diabetes.Curr with res Opin 2004;20:1377.

331. Goldstein I, Jones La, Belkoff LH et al: Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double blind study in men with diabetes mellitus.Mayo Clin Proc 2012;87:843.

332. Goldstein I, Young JM, Fischer J et al: Vardenafil, a new inhibitor of phosphodiesterase type 5, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed dose study.26:777.

333. Grover-Paez F, Villegas Rivera G and Guillen Ortiz R: Sildenafil Citrate reduces microalbuminuria and the percentage of A1c in male patients with type diabetes type 2. Diabetes Res Clin Pract 2007;78:136.

30 diabetes met 2008;25:138.

335. Ishii n, Nagao K, Fujikawa K et al: Vardenafil 20 mg demonstrated superior efficiency up to 10 mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.Thin J Urol 2006;13:1066.

336. Kirilmaz U, Guzel O, Aslan Y et al: The effect of lifestyle adjustment and glycemic control of the effectiveness of sildenafil-citrate in patients with erectile dysfunction as a result of type-2 diabetes mellitus.18:244.

337. Lee JW, Park HJ and Park NC: Serum High sensitivity C-reactive protein levels and response at 5 mg Tadalafil once a day in patients with erectile dysfunction and diabetes.Korean J Urol 2013;54:858.

338. Hamidi Madani A, Asadolahzade A, Mokhtari g et al: assessment of the effectiveness of combination therapy with folic acid and tadalafil for dealing with erectile dysfunction in men with type 2 diabetes mellitus.j with 2013;10:1146.

339. Morano S, Mandosi e, Fallarino M et al: Antioxidant -Therapy associated With Sildenafil, reduces activation and markers of monocytes and markers for endonic damage in patients with diabetic erectile disorders: a double -blind, placebo -controlled study.EUR Urol 2007;52:1768.

340.43:387.

341. Perimenis P, Markou S, Gyftopoulos K et al: Shift of long -term treatment with self -removals to oral sildenafil in diabetes patients with serious erectile dysfunction.EUR UROL 2002;41:387.

342. Popovic S, Nale D, Dabic M et al: Effect of tadadafil on erectile dysfunction in male patients with diabetes mellitus.vojnosanite pregl 2007;64:399.

343. Price de, went jc, pi-verdee s al: sildenafil: study of a new oral treatment of erectile dysfunction in diabetic men.15:821.

344. Rendell MS, Rajfer J, Wicker Pa et al: Sildenafil For the treatment of erectile dysfunction in men with diabetes: a randomized controlled experiment.Sildenafil Diabetes Study Group.jama 1999;281:421.

345. Saenz de Tejada I, Anglin G, Knight Jrdiabetes Care 2002;25:2159.

346. Safarinejad MR: Oral Sildenafil In the treatment of erectile dysfunction in diabetic men: a randomized double blind and placebo -controlled research.J Diabetes complications 2004;18:205.

347. Santi D, Granata AR, Guidi a et al: Six months of daily treatment with Vardenafil improves the parameters for endothelium -flames and hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double blind, prospectus steek test.Eeur J Endocrinol 2016;174:513.

348. Stuckey BG, Jadzinsky MN, Murphy LJ et al: Sildenafil Citrate to treat erectile dysfunction in men with type 1 diabetes: results of a randomized controlled experiment.iabetes care 2003;26:279.

349. Zamorano-Leon JJ, Olivier C, De Las Heras n et al: Vardenafil improves the erection of the penis in diabetes mellitus type 2 with erectile dysfunction: tropomyosin role.J sex with 2013;10:3110.

350.3:883.

353. Shabsight and Matterntern A: Revitalize: a large observation study that assesses the safety and effectiveness of VARDEAFIL in men with erectile dysfunction and metabolic syndrome sex with 2016;4: E135.

354. Suetomi t, Kawai K, Hinotsu in Al: Negative influence of metabolic syndrome on responsiveness on Sildenafil in Japanese men.J sex with 2008;5:1443.

355. Dadkhah f, Safarinejad MR, Asgari Ma et al: Atorvastatin improves the reaction of Sildenafil in hypercholesterolemic men with erectile dysfunction that does not originally respond to sildenafil.int J Impot Res 2010;22:51.

356. Miner M, Gilderman L, Bailen J et al: Vardenafil in men with stable statin treatment and dyslipidemia.j sex with 2008;5:1455.

357. Mines etc., Barnes A and Janning S: Efficiency of phosphodiesterase Type 5 Remmer Therapy in men with erectile dysfunction and dyslipidemia: a post -hoc analysis of Vardenafil -Statin -Study.j sex with 2010;7:1937.

358. Albuquerque DC, Miziara LJ, Saraiva JF et alint braz J urol 2005;31:342.

359. Aranda P, exchange lm, Calvo c et al: Erectding dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish national study.Am J Hypertens 2004;17:139.

360. Clones RA, Brown M, Price LM et al: Effect of Sildenafil in patients with erectile dysfunction who need antihypertensive therapy.Sildenafil Study Group.am J Hypertens 2001;14:70.

361. Kloner Ra, Sadovsky R, Johnson Eg et al: Tadalafil's efficiency in the treatment of erectile dysfunction in hypertensive men on simultaneous Thiazid Diuretic therapy.Int Jute Impot Res 2005;17:450.

362. Park HJ, Park NC, Shim HB et al: an open clear, multicenter, flexible dose research to evaluate the efficiency and safety of Viagra (sildenafilcitrate) in Korean men with erectile dysfunction and arterial hypertension that takes anti -hypertensive agents.J sex with 2008;5:2405.

363. Pickering TG, Shepherd am, Puddey in et al: Sildenafil Citrate for erectile dysfunction in men who receive several antihypertensive remedies: a randomized controlled study.Am J Hypertens 2004;17:1135.

364. Van Ahlen H, Wahle K, Kupper W et al: Security and efficiency of Vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with different antihypertertives.j sex with 2005;2:856.

365. Freitas D, Athanazio R, Almeida D et al: Sildenafil improves the quality of life in men with heart failure and erectile dysfunction.Tin J Impot res 2006;18:210.

366. Katz SD, Parker JD, Glasser DB et al: Efficiency and safety of sildenafilcitrate in men with erectile dysfunction and chronic heart failure.Am J Cardiol 2005;95:36.

367. Webster LJ, Michelakis Ed, Davis t et al: Use of sildenafil for safe improvement of erectile function and quality in men with New York Heart Association Classes II and III cone stiff heart failure: a prospectus, placebo -generated, double blind crossover-test.Arrow internally with 2004;164:514.

368. Conti CR, Pepine CJ and Sweney M: Efficiency and safety of sildenafilcitrate in the treatment of erectile dysfunction in patients with ischemic heart disease.Am J Cardiol 1999;83:To ask.

369. Debusk RF, Pepine CJ, Glasser DB et al: Efficiency and safety of sildenafilcitrate in men with erectile dysfunction and stable coronary artery disease.Am J Cardiol 2004;93:147.

370. Bocchio M, Peleliccione F, Mihalca r et al: Treatment of erectile dysfunction reduces the psychological note.32:74.

371. Buranakitjaro P, Manglabruks A, Leungwattanakij s et al: Efficiency and safety of sildenafil in Asian men with erectile dysfunction and cardiovascular risk.90:1100.

372. Olsson am and Persson CA: Efficiency and safety of Sildenafil Citrate to treat erectile dysfunction in men with heart -sea -sea -disease.55:171.

373. Rubio-Aurioles E, Porst H, Eardley in et al: Comparison of Vardenafil and Sildenafil In the treatment of men with erectile dysfunction and risk factors for cardiovascular diseases: a randomized, double blind, total crossover study.J Sex with 2006;3:1037.

374. Vicari e, Malaguarnera M, La Vignera s et al: Efficiency and limits of Sildenafil -Citrate in patients with arterial erectile dysfunction: peripheral arterial disease and cardiovascular comorbidities.Asian J Androl 2008;10:847.

375. Abolyosr A, Elsagheer GA, Abdel framework MS et al: Evaluation of the effect of sildenafil and/or doxazosin on benign prostatathyperplasi-related lower urinary tract symptoms and erectile dysfunction.5:237.

376. Choi H, Kim JH, Shim Js et al: Comparison of the efficiency and safety of 5 mg once a day against 5 mg alternative day tadalafil in men with erectile dysfunction and lower urinary tract symptoms.27:33.

377. Egerdie rb, auerbach s, roehrborn cg et al: tadalafil 2.5 or 5 mg once daily for 12 weeks administered in men with both erectile dysfunctions and symptoms of benign prostatepahuperplasia: results of a randomized, placebo-check, double double check-Double-Double-Double-Double-Double-Double-Double-Blind Study.J Sex with 2012;9:271.

378. Eryildirim B, Aktas A, Kuyumcuoglu U et al: The effectiveness of sildenafil -citrate in patients with erectile dysfunction and lower urine system systems and the importance of asymptomatic inflammatory prostatitis.22:349.

379. Giuliano Fortamsulosine-controlled, 12-week double blind study. J Sex with 2013;10:857.

380. Jin Z, Zhang Zc, Liu Jh et al: An open, comparative multicenter clinical examination of combined oral therapy with sildenafil and doxazosin gits for the treatment of Chinese patients with erectile dysfunction and lower urinary trees Symptoms SECondary hyperplasia.;13:630.

381. Kaplan SA, Gonzalez RR and Te AE: Combination of alphauosine and sildenafil is better than monotherapy for the treatment of lower urinary tract symptoms and erectile dysfunction.EUR Urol 2007;51:1717.

382. Lee JY, Park Sy, Jeong Ty et al: Combined Tadalafil and Alfa-blocking therapy for benign prostate home patients in patients with erectile dysfunction: a multicenter, prospective study.J Androl 2012;33:397.

383. Liguori g, drumbetta C, the Giorgi G et al: Efficiency and safety in combined oral therapy with tadalafil and alphauosine: an integrated approach to patients with lower urinary tracts symptoms and erectile disorders.6:544.

384. McVary KT, Kaufman J, Young JM et al: Sildenafil Citrate improves the erectile function: a randomized double -blind sample with open life expansion.Int J Clin Pract 2007;61:1843.

385. McVary KT, Monigy W, Camps JL, Jr.et Al: Sildenafil Citrate improves the erectile function and urine symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatian hyperplasia: a randomized, double study.J Urol 2007;177:1071.

386. Mulhall JP, Guhring P, Parker M et al: Assessment of the impact of Sildenafil -Citrate on lower urinary tract symptoms in men with erectile dysfunction.J sex with 2006;3:662.

387. Porst H, McVary KT, Montorsi f all: Effects of tadalafil once a day on the erecting substances in men with erectile dysfunction and drawing and symptoms of benign prostatic hyperplasia. Urol 2009;56:727.

388. Porst H, Roehrborn CG, Secrest RJ et al.Klinic Studies.J Sex with 2013;10:2044.

389. Tuncel A, Nalcacioglu V, honorary K et al: Sildenafil Citrate and Tamsulosine combination is no better than monotherapy for the treatment of lower urinary tract symptoms and erectile dysfunction.World J Urol 2010;28:17.

390. Maselli G, Bergamasco L, Silvestri V et al: Tadalafil versus Solifenacin For persistent storage symptoms after prostat surgery in patients with erectile dysfunction: a prospective randomized study.The J Urol 2011;18:515.

391124:147.

392. Perimenis P, Karkoulias K, Markou s et al: Erection dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the effectiveness of sildenafil and continuously positive airway pressure.Thin J Impot res 2004;16:256.

393. Perimenis P, Constantinopoulos A, Karkoulias K et39:547.

394. Condorelli RA, Calogero AE, Di Mauro M et al: Effects of Tadalafil treatment combined with physical activity in patients with low initial hypogonadism: results of a non-randomized single Armpage 2 study.Allling Male 2016;3: 155.

395. Kennedy SH, Dugre H and Depoy I: a multicenter, double blind, placebo-controlled study of sildenafilcitrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of a large depressive disorder.26:151.

396. Rosen R, Shabsight, Berber M et al: Efficiency and tolerability of Vartafil in men with mild depression and erectile dysfunction: the depression-related improvement with Vandafil to erectile response research.Am J Psychiatry 2006;163:79.

397. Seidman SN, Roose SP, Menza Ma et al.am J Psychiatry 2001;158:1623.

398. Aizenberg D, Weizman A and Barak Y: Sildenafil for selective serotonin resumed by Remmer -induced erectile dysfunction in older male depressive patients.J Sex Marital Ther 2003;29:297.

399. Evliyaoglu Y, Y system K, Coins M et al: Efficiency and tolerability of Tadalafil to treat erectile dysfunction in men who use serotonin CV inhibitors.Ourology 2011;77:1137.

400. Fava M, Nurnberg HG, Seidman SN et alj Clin Psychiatry 2006;67:240.

403. Nurnberg HG, Hensley PL, Gelenberg AJ et al: Treatment of antidepressant-associated sexual dysfunction with Sildenafil: a randomized controlled study.Jama 2003;289:56.

404. Segraves RT, Lee J, Stevenson r et al: Tadadafil for the treatment of erectile dysfunction in men in antidepressants.j clin psychopharmacol 2007;27:62.

405. Tignol J, Furlan PM, Gomez-Beneyto M et al: Efficiency of sildenafilcitrate (Viagra) for the treatment of erectile dysfunction in men in remission of depression.Int Clin Psychopharmacol 2004;19:191.

406. Karami H, Hassanzadeh-Hadad A and Fallah-Karkan M: comparison of monotherapy with tadalafil or tamsulosin and their combination therapy in men with benign prostatian hyperplasia: a randomized clinical study.urol J 2016;13:2920.

407. OZCAN L, Polat EC, Kocaaslan r et al: Effects of taking Tadalafil 5 mg once a day at erectile function and total testosterone levels in patients with metabolic syndrome.andrologia 2017;49: 12751.

408. Lee LK, Goren A, Boysov Nn et al: Treatment satisfaction in men with simultaneous benign prostatathyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibition combinations.10:1205.

409. Bolat MS, Ozer I, Cinar o et al: The effectiveness of low dose Tadalafil in patients who undergo hemodialysis with kidney disease in the final stage.39:582.

410. AZABs, AOUD H and Nabil Nable N: the correlation between C-reactive protein with high sensitivity and erectile dysfunction treated with hypertension treated with Vandafil.int J Impot Res 2017;29:82.

411. OHL DA, Carlsson M, Stecher vj et al: Efficiency and safety of sildenafil in men with sexual dysfunction and spinal cord slu*t.5: 521.

412. Bannowsky A, Schulze H, Van der Horst c et al: Recovery of erectile function after nerve -saving radical prostatectomy: improvement with nocturnal layer -dose sildenafil.bju int 2008;101:1279.

413. Bannowsky A, Van Ahlen H and Loch T: Increase in the dose of Vardenafil on a daily basis does not improve the erectile function after one -sided nerve -saving radical prostatectomy.J sex with 2012;9:1448.

414. Mixed DS, Sanchez-Tortiz RF, Wein AJ et al: Efficiency of Sildenafil in erectile dysfunction after radical prostatectomy.int j Impot res 2000;12:165.

415. Briganti a, di trapani e, abdollah f et al: choosing the best candidates for Penilehabilitation after bilateral nerve -saving radical prostatectomy.j sex with 2012;9:608.

416. Brock G, Nehra A, Lipshultz Li et al: Safety and efficiency of Vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy.j urol 2003;170:1278.

417. Canat L, Guner B, Gurbuz C et al: Effects of three times per week against on-demand Tadalafil treatment on erectile function and continuity recovery after bilateral nerve that saves radical prostatectomy: results of a potential, randomized and Single-center study.Kaohsiung J with SCI 2015;31:90.

418. Cathala N, Mombet A, Sanchez-Salas r et al: Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.Can J Urol 2012;19:6328.

419. Cavallini g, Modenini F, Vitali G et al: Acetyl-L-Carnitine Plus Propionyl-L-Carnitine improves the effectiveness of Sildenafil to treat erectile dysfunction after bilateral nerve-saving radical prostatectomy.urology 2005;66:1080.

420. Feng Mi, Huang S, Captain J et al: Effect of Sildenafil Citrate on post-radical prostomy erectile dysfunction.J UROL 2000;164:1935.

421. Hirik E, Bozkurt A, Karabakan M et al: Results of Tadalafil treatment in patients after an open nerve-saving radical prostatectomy.Arch Ital Urol Androl 2016;88:4.

422. Hubanks JM, Umbreit EC, Karnes RJ et al: Open radical retropubic prostatectomy with high front release of Levator fascia and constant Haptic feedback in bilateral neurovascular bundt protection plus early postoperative phosphodiesterase -tertype;61:878.

423. Kim DJ, Hawksworth DJ, Hurwitz LM et al: A prospective, randomized, placebo-controlled test with on-demand vs.nocturnal Sildenafil Citrate as rated by Rigiscan and the International Index for Erectile Function.andrology;4:27.

424. Kimura M, Caso JR, Banez Ll et al: Prediction of participation in and successful result of a penishabilitation program using a phosphodiestase type 5 inhibitor with a vacuum erection interior after radical prostatectomy.Bju int 2012;110:Rust 1.

425. Lee IH, Sadetsky N, Carroll pr et al: The effect of treatment choices for localized prostate cancer of the response to phosphodiesteraser inhibitors.j Urol 2008;179:1072.

426. Lowenitritt BH, Scarddino Pt, Miles BJ et al: Silver cateral radical retrobiskam.j urol 1999;162:1614.

427. McCullough AR, Hellstrom wg, Wang r et al: Restoring erectile function after nerve, scarce radical prostatectomy and penishabilitation with nocturnal intraurethral alprostadil versus sildenafil citrat.j urol 2010;183:2451.

428. Megas G, Papadopoulos G, Stathouros G et al: Comparison of efficiency and satisfaction profile, between Penil-PROPHESE Implantation and oral PDE5 brakes Tadalafil therapy, in men with nerve-saving radical prostatectomy erection dysfunction.Bju int 2013;112:J 169.

429. Montorsi F, Brock G, Lee J et al: Effect of nocturnal versus on-demand Varden on the improvement of the erectile function in men after bilateral nerve-saving radical prostatectomy.EUR Urol 2008;54:924.

430. Montorsi F, Brock G, Stolzenburg Ju et al: Effects of tadalafil treatment on recovery of erectile function after bilateral nerve-saving radical prostatectomy: a randomized placebo-controlled study (reactt).Eeur Urol 2014;65:587.

431. Patel HR, ILO D, Shah n et al: Effects of tadalafil treatment after bilateral nerve-saving radical prostatectomy: quality of life, psychosocial results and treatment satisfaction is the result of a randomized, placebo-descontrolated phase IV study.BMC.BMC;15:31.

432. Montorsi F, Nathan HP, McCullough a et al: Tadalafil In the treatment of erectile dysfunction after bilateral nerve that saves radical retrobrisic prostatectomy: a randomized, double-blind, placebo-controlled study.J Urol 2004;172:1036.

433. Mulhall JP, Burnett Al, Wang r et al: A phase 3, placebo -checked study of the safety and effectiveness of Avanafil to treat erectile dysfunction after nerve saving radical prostatectomy.j urol 2013;189:2229.

434. Nakano y, Miyake H, Chiba K et16:892.

435. Nehra A, Grantmyre J, Nadel a et al: Vardenafil improved the satisfaction of the patient with erectile hardness, org*smic function and sexual experience in men with erectile dysfunction after nerve that radical prostatectomy has saved.J Urol 2005;173:2067.

436. Ogura K, Ichikoka K, Terada n Al: Sildenafil -Citrate's role in the treatment of erectile dysfunction after radical retrobic prostatectomy.int J Urol 2004;11:159.

437. Pace G, del Rosso A in vicentini C: Penilehabilitatitatherapie n radical prostatectomy.32:1204.

438. Padma-Nathan H, McCullough AR, Levine la et al: Randomized, double blind, placebo-controlled study of postoperative nocturnal sildenafilcitrate to prevent erectile dysfunction after bilateral nerve-saving radical prostatectomy.20:479.

439. Pavlovich CP, Levinson AW, SU LM et al: Nocturnal vs on-demand sildenafil for penile habilitation after minimal invasive nerve-saving radical prostatectomy: results of a randomized double-blind study with placebo.bju int 2013;112:844.

440. Raina R, Agarwal A, Allamansi Ss et al: Sildenafil Citrate and vacuum limit combination improves sexual satisfaction in erectile dysfunction after radical prostatectomie.urology 2005;65:360.

441. Raina R, Lakin MM, AGARWAL A ET AL: Long -term intraca -nosy therapy sponsors may be able to switch to Sildenafilcitrate after radical prostatectomie.urology 2004;63:532.

442. Raina R, Lakin MM, AGARWAL A ET AL: Efficiency and factors associated with a successful result of the use of Sildenafil -Citrate to erectile dysfunction after radical prostatectomie.urology 2004;63:960.

443. Raina R, Lakin MM, Agarwal a et al: Long-term effect of sildenafil-citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.urology 2003;62:110.

444. SEO YE, KIM SD, KIM TH E AT: The effectiveness and safety of Tadalafil 5 mg once a day in the treatment of erectile dysfunction after robot-supported laparoscopic radical radical prostatectomy: 1-year follow-up.corean J Urol 2014;55:112.

445. Zagaja GP, the best of the best of the best of the best of et al: sildenafil in thirteen of erectile dysfunction after radical prostatectomy.urology 2000;56:631.

446. CD zippe, Jhaveri FM, Klein Ea et al: viagra -Rol na radical prostatectomy.urology 2000;55:241.

447. Zippe CD, Kedia AW, Kedia K et al: Treatment of erectile dysfunction after radical prostatectomy with sildenafil -citrate (Viagra) .urology 1998;52:963.

448. Watkins Bruner D, James JL, Bryan CJ et al.;8:1228.

449. Harrington C, Campbell G, Wynne C et al: randomized, placebo-controlled, crossover investigations with sildenafilcitrate in the treatment of erectile dysfunction after external radiation radiation treatment of prostate cancer.J with imaging radiat oncol 2010;54:224.

450. Ilic D, Hindson B, duch*esne G et al: A randomized, double-blind, placebo-controlled experiment with nocturnal sildenafilcitrate to retain erectile function after radiation treatment for prostate cancer.J with imaging radiat oncol 2013;57:81.

453. PCROCCRES L, Butcher C, Slob AK An albeam radiation treatment for prostatakarcinom. In J Radiat Oncol Biol Phys 2006;66: 439.

454. Placci L, Slob AK and HOP WC: Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open label extension of a blind study.Ourology 2007;70: 1190.

455. Kedia S, Zippe CD, Agarwal a et al: Treatment of erectile dysfunction with sildenafilcitrate (Viagra) after radiotherapy for prostate cancer.urology 1999;54: 308.

456. Merrick GS, Butler WM, Lief Jh et al: Efficiency of sildenafilcitrate in patients with prostate -brachytherapy with erectile dysfunction.Ourology 1999;53: 1112.

457. Ohebshalom M, Parker M, Guhring P et al: The effectiveness of Sildenafil -Citrate after radiotherapy for prostate cancer: temporary considerations.J Urol 2005;174: 258.

458. Pahlajani G, Raina R, Jones JS et al: Early intervention with phosphodiesterase-5 inhibitors after prostate-brachytherapy improves the subsequent erectile function.Bju int 2010;106: 1524.

459. Pisansky TM, Pugh SL, Greenberg Re et al: Tadalafil to prevent erectile dysfunction after radiotherapy for prostate cancer: radiotherapy -oncology group [0831] Randomized clinical test.jama 2014;311: 1300.

460. Potters L, Torre T, Fearn Pa E Al: Strength after permanent prostate brachyterapy for local prostate seals.Thine J Radiat Oncol Biol Phys 2001;50: 1235.

461. Roina R, AGARWAL A, GYAL KK et al: Long-term strength after IOD-125 Radiation therapy for prostate cancer and roll of Sildenafil Citrate.urology 2003;62: 1103.

462. Ricardi U, Gontero P, Ciammella P et al: Efficiency and safety of Tadalafil 20 mg on Demand vs.tadalafil 5 mg once a day in the treatment of erectile dysfunction in prostate cancer: a randomized phase IIF -Experiment.j sex with 2010;7: 2851.

463. Schiff JD, Bar-Chama N, Cesaretti J et al: Early use of a phosphodiesteraser inhibitor after bracherapy repairs and retains erectile function.Bju int 2006;98: 1255.

464. Shemtov, Radomski SB and Crook J: Success of Sildenafil to erectile dysfunction treated with brachy therapy or external radiation for prostate acancer.Can J Urol 2004;11: 2450.

465. TELLAKEN PE, OHALAL M, MOHIDEN N E AT: Analysis of the effect of Androgen Deficiency Therapy on Sildenafilcitrate Response after radiotherapy for prostate cancer.J Urol 2007;178: 2521.

466. TELLAKEN PE, Parker M, Mohiden n et al: predictors for response to Sildenafil Citrate after radiotherapy for prostate cancer.J sex with 2009;6: 1135.

467. Valicenti RK, Choi e, Chen C et al: Sildenafil Citrate changes effectively sexual dysfunction induced by three -dimensional conformity radiotherapy.urology 2001;57: 769.

468. Weber DC, Bieri S, Kurtz JM et al: Prospective pilot examination of Sildenafil to treat post -radiotherapy erectile dysfunction in patients with prostate cancer.j clin oncol 1999;17: 3444.

469. Zelefsky MJ, McKee AB, Lee H et: Efficiency of oral Sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma in prostata.urology 1999;53: 775.

470. Zelefsky MJ, Shasha D, Branco Rd et al: Prophylactic Sildenafilcitraat improves selected aspects of sexual function in men treated with radiotherapy for prostate cancer.j urol 2014;192: 868.

471. Chen J, Mabjesh NJ, Greenstein a et al: Clinical efficiency of sildenafil in patients with chronic dialysis.J UROL 2001;165: 819.

472. Hyodo t, Ishida H, Masui n et al: Kidney diseases Life quality for Japanese dialysis patients Words to manage sildenafil and treatment of erectile dysfunction with sildenafil.her Apher Dial 2004;8: 340.

473. Rosas SE, Wasserstein A, Kobrin s et al: Provisional observations of Sildenafil treatment for erectile disorders of dialysis patients.Am J Kidney Dis 2001;37: 134.

474. Seibel I, Poli the FigueIredo CE, counting C et al: Efficiency of oral herring file in hemodialysis patients with erectile dysfunction.J am Soc Nephrol 2002;13: 2770.

475. Tas A, Ersoy A, Ersoy C et al: Efficiency of sildenafil in male dialysis patients with erectile dysfunction does not respond to erytropoietin and/or testosterone treatments.18: 61.

476. Turk S, Karalezli G, Tonbul HZ et al: Erectding dysfunction and the effects of Sildenafil treatment in patients on hemodialysis and continuous outpatient peritoneal dialysisis.Down -colored dial transplantation 2001;16: 1818.

477. Turk S, Solak Y, Can S et al: Effects of Sildenafil and Varden on erectile dysfunction and health-related quality of life in hemodialysis patients: a prospective randomized crossover study.Reprol Dial Transplant 2010;25: 3729.

478.90: 442.

479. Barrou B, Cuzin B, Malavaud B et al: Early experience with Sildenafil for the treatment of erectile dysfunction at recipients of kidney transplantation.18: 411.

480. Demir e, Balal M, Paydas s et al: Efficiency and safety of Vardenafil with recipients of kidney transplantation with erectile dysfunction.Transplantation PR 2006;38: 1379.

481. Prieto Castro RM, Anglada Curado FJ, Regueiro Lopez JC et al: Treatment with sildenafilcitrate in kidney transplant patients with erectile dysfunction.bju int 2001;88: 241.

482. RUSSO D, Musone D, Alter v et al: Erectding dysfunction in kidney transplanted patients: Efficiency of sildenafil.j Nephrol 2004;17: 291.

483. Sharma RK, PRASAD N, Gupta a et al: Treatment of erectile dysfunction with sildenafilcitrate in recipients of Nierallograft: a randomized, double blind, placebo-controlled, crossover test.am J Kidney Dis 2006;48: 128.

484. Zhang Y, Guan DL, OU TE Al: Sildenafil Citrate treatment for erectile dysfunction after kidney transplantation.37: 2100.

485. Derry Fa, Dinsmore WW, sentences with: Effectiveness and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord glutsel.Neurology 1998;51: 1629.

486. Ergin s, Gunduz B, Ugurlu H he Alog Erectile Disorders.J Ruggenmerg with 2008;31: 522.

487. Goose WH, Zaslau S, Wheeler s et al: Efficiency and safety for oral sildenafil in men with erectile dysfunction and spinal cord glazsel.J -Ruggenmerg with 2001;24: 35.

488. Giuliano F, Hultling C, El Mashy Ws et al: Sildenafil Citrate (Viagra®): a new oral treatment of erectile dysfunction caused by traumatic spinal cord slu*t.Tin J Clin Pract Suppl.1999;102: 30.

489. Giuliano F, Rubio aroles E, Kennelly M et al: Efficiency and safety of VarmEafil in men with erectile dysfunction caused by spinal cord glutsel.Neurology 2006;66: 210.

490. Giuliano F, Sanchez-Ramos A, Lochter-Ernst d et al: Efficiency and safety of Tadalafil in men with erectile dysfunction after spinal cord glutsel.Arch Neurol 2007;64: 1584.

491. Khorrami MH, Javid A, Moshtaghi D et al: Sildenafil -Efficiency in erectile dysfunction Secondary to spinal cord damage depends on the level of wiring damage.33: 861.

492. Kimoto Y, Sakamoto S, Fujikawa K et al: Up titration of Varmena-fi l dose from 10 mg to 20 mg improved erectile function in men with spinal cord slu*t.The J Urol 2006;13: 1428.

493. Lombardi G, Macchiarella A, Cecconi f et al: Ten years Fosfodiesterase Type 5 inhibitors in injured patients with spinal cord.J sex with 2009;6: 1248.

494. Manou BK, from Tam PN, Sesay M et al: Effect of Sildenafil on erectile dysfunction in patients with spinal cord injured.43: 132.

495. Maytom MC, Derry Fa, Dinsmore WWT et al: A two -part pilot examination of Sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord slu*tel.Spinal cord 1999;37: 110.

496. Moemen MN, Fahmy I, Abdelaal M et al: Erectile dysfunction in spinal cord -lasting damaged men: Different treatment options.Tht J Impot Res 2008;20: 181.

497. Sanchez Ramos A, Vidal J, Jouregui ML et al: Efficiency, safety and predictable factors for therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cords.spinal Cord 2001;39: 637.

498. Suns JM, Previnaire JG, Denys p et al: phosphodiesteraser inhibitors in the treatment of erectile dysfunction at men damaged by the spinal cord.Spinal cord 2007;45: 169.

499. Tuzgen S, Karamehmetoglu SS, Karacan in et al: Use of sildenafil to treat erectile dysfunction in patients with spinal cord.16: 40.

500. Miller No and Arnold AC: Current concepts in the diagnosis, pathogenesis and handling of non -arterite forefront ischemic optical neuropathy.eye (Lond) 2015;29: 65.

501. Lee MS, Grossman D, Arnold Ac et al: Performance of non -arteritic for the ischemic optical neuropathy: increased risk in diabetes patients.Opalmology 2011;118: 959.

502. ZOTZ RB, Finger C, Scharf Re36: 46.

503. Campbell UB, Walker am, Gaffney M et al: Acute non -Arterithic Front Ischemic optical neuropathy and exposure to phosphodiesterase type 5 inhibitors.J Gender with 2015;12: 139.

504. Margo CE and French DD: Ischemic optical neuropathy in male veterans Ordered phosphodiesterase-5 handmere.Am j Ophthalmol 2007;143: 538.

505. Flahavan EM, Li H, Guptte-Singh K et105: 76.

506. Pomeranz HD: Relationship between phosphodiesterase-5 inhibitors and non-arteritic forchemical optical neuropathy.j neuroprophthalmol 2016;36: 193.

507. Li WQ, Qureshi AA, Robinson KC et al: Sildenafil -Use and increased risk of event melanoma in American men: a potential cohort study.Jama Internal with 2014;174: 964.

508. Loebs, Folkvaljon Y, Lambe with Al: Use of phosphodiesterase type 5 inhibitors to erectile dysfunction and risk of malignant melanoma.Jama 2015;313: 2449.

509. Lian Y, Yin H, Pollak Mn et al: Phosphodiesterase Type 5 inhibitors and the risk of melanoma skin cancer.EUR UROL 2016;70: 808.

510. Pottegard A, Schmidt SA, Olesen AB et al: Use of Sildenafil or other phosphodiestera inhibitors and the risk of melanoma.B Cancer 2016;115: 895.

511. Matthews A, Langan SM, Douglas IJ et al.plos met 2016;13: E1002037.

512. Hill AB: the environment and the disease: association or causal compensation?58: 295.

513. Michl U, Molfenter F, Graefen M et al: Use of phosphodiesterase type 5 inhibitors can have a negative effect on biochemical relapse after radical prostateectomy.J Urol 2015;193: 479.

514. Gallina A, Bianchi M, Gandaglia G et al: A detailed analysis of the connection between postoperative phosphodiesterase type 5 -in -the use and the risk of biochemical relapse after radical prostatectomy.eur Urol 2015;68: 750.

515. Loebs, Folkvaljon Y, Robinson D et al: Phosphodiesterase Type 5 -inpaters use and pathogen's care after prostate treatment.EUR UROL 2016;70: 824.

516. Jamnagerwalla J, Howard Le, Vidal AC et al: The connection between phosphodiesterase type 5 inhibitors and prostate cancer: results of reduced study.J Urol 2016;196: 715.

517. Atiemo Ho, Szostak MJ and SKKLAR GN: Salvage or Sildenafil -Ror Referred from doctors in primary care.j Urol 2003;170: 2356.

51. Jian, Clats, and washs hate sclafile - -Clame 2004;16: 64.

519. Hatzichristou D, Moysidis K, Apostolidis a et al: Sildenafil error can be due to insufficient patient instructions and follow-up: a study of 100 non-Respondent.eur Urol 2005;47: 518.

520. Gruenwald I, Shenfeld O, Chen J et al: Positive effect of counseling and dose adjustment in patients with erectile dysfunction who have not achieved treatment with sildenafil.eur Urol 2006;50: 134.

521. Kim Ed, Seftel Ad, Goldfischer is an ALH sex with 2013;11: 820.

522. Carson CC, Hatzichristou DG, Carrier s et al: Erectile response with Vardenafil in Sildenafil Non-answer: a multicenter, double blind, 12-week, flexible dose, placebo-controlled erectile disorders clinical dysfectation.Bju int 2004;94: 1301.

523. Brisson Tea, Embroidery GA, Thiel Dd et al: Vardenafil Rescue Figures For Sildenafil -Me -Outshare: Objective assessment of 327 patients with erectile dysfunction.urology 2006;68: 397.

524. Ozgur BC, Goonenc F and Yazicioglu AH: Sildenafil or Vardenafil Not -Sfesk 'Erectile reaction to tadalafil.urol J 2009;6: 267.

525. Wespes E, Ramlam a en garbar C: Sildenafil Non-respons: Hemodynamische en morftometrische Studies.Eur urol 2005;48:136.

526. Salonia A, Adaikan G, Buvat J et al: Sexual rehabilitation after the treatment of prostate part 2: recommendations of the fourth international consultation for sexual medicine (ICSM 2015) .J Sex with 2017;14: 297.

527. Salonia A, Adaikan G, Buvat J et al: Sexual rehabilitation after the treatment of prostate part 1: recommendations of the fourth international consultation for sexual medicine (ICSM 2015) .J Sex with 2017;14: 285.

528. Sopko Na and Bunnett Al: erection validation after prostatectomy - current strategies and future directions.13: 216.

529. Basal S, Wambi C, Acikel C et al: Optimal strategy for Penilrehabilitation After robot -like radical prostatectomy based on preoperative erectile function.bju int 2013;111: 658.

530. Fode M, Seefoglu EC, Albersen M et al: Sexuality after radical prostatectomy: Is recovery from erectile function sufficient?5: 110.

531. Walz J, Epstein Ji, Ganzer r et al: A critical analysis of the current knowledge of surgical anatomy of prostate related to optimization of cancer control and preservation of continuity and erection for candidates for radical prostatectomy: an update. Urol 2016;70: 301.

532. Nguyen ln, Head L, Witiuk K et al: Risks and benefits of Kaverneuze Neurovascular Bundt, stored under radical prostatectomy: a systematic review and Meta -analysis.j Urol 2017;198: 760.

533. Schover LR, Fouladi RT, Warneke CL et al: Using treatments for erectile dysfunction among the survivors of prostatacarcinom.95: 2397.

534. Donovan KA, Walker LM, Wassersug RJ et al: Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.121: 4286.

535. Nelson CJ and Kenowitz J: communication and intimacy -promoting interventions for men with the diagnosis of prostate cancer and their partners.J sex with 2013;10Suppl 1: 127.

536. Tal R, Alphs HH, Cancer P et al: Erectile Functional recovery after radical prostatectomy: a meta -analysis.j sex with 2009;6: 2538.

537. Al-Apry M, Steineck G, Agren Cronqvist AK et al: Improving the preservation of erectile function after external radiotherapy for prostate cancer.Radiiother oncol 2000;57: 201.

538. van der Wiielen GJ, Van Putten WL and Plocrocti L: Sexual function after three-dimensional conformity radiation therapy for prostate cancer: results of a dose-peeling experiment.Tht J Radiat Oncol Biol Phys 2007;68: 479.

539. Burnett Al, Aus G, Canby-Hagino Ed et al: Erectile Functional result reporting after clinically located prostate cancer treatment.J Urol 2007;178: 597.

540. Ficarra V, Novara G, Ahleting in Et Al: Systematic review and Meta analysis of studies that report the Robot -assisted radical prostatectomy.EUR UROL 2012;62: 418.

541. Rabbani F, Schiff J, Piectuch M et al: Time course for recycling erectile function after radical retropubic prostatectomy: someone goes after 2 years?7: 3984.

542. Nelson CJ, Scardino PT, Eastham Ja et al: Back to Baseline: Recovery of erectile function after radical prostatectomy from the patient's perspective.J sex with 2013;10: 1636.

543. Litwin MS, Flanders SC, Pasta DJ et al: Sexual function and after radical prostatectomy or radiation for prostate cancer: multivariat life quality analysis of capsure.Apse cancer in the strategic research action at prostata.urology;54: 503.

544. Mahmood J, Shamah Aa, Creed TM et al: Erectorships induced by radiation: recent progress and future direction.Adv Radiat Oncol 2016;1: 161.

545. Mulhall JP, Bella AJ, Briganti a et al: erectile functional rehabilitation of the radical prostatectomie patient.J sex with 2010;7: 1687.

546. Burnett Al and Lue TF: Neuromodulating therapy to improve the results of restoring erectile function after the functioning of the pelvis.J Urol 2006;176: 882.

547. Weyne E, Castiglione F, Van der Aa f al: Orientation points in restoring erectile function after radical prostatectomy.Wet Reef Urol 2015;12: 289.

548. Ryu JK, Suh JK and Burnett Al: research into pharmacotherapy for erectile dysfunction.Revise Androl Urol 2017;6: 207.

549. Segal RL, Bivalacqua TJ and Burnett Al: current Penilrehabilitation strategies: Clinical proof.Arab J Urol 2013;11: 230.

550. Sadovsky R, Basson R, Krychman M et al: kits a sexual problem.J Six Met 2010;7: 349.

553. Aversa A, Isidori am, Spera G et al: Androgens improves Kaernø's vasodilatation and response to Sildenafil in patients with erectile dysfunction.Clin Endocrinol (Oxf) 2003;58: 632.

554. Buvat J, Montorsi F, Maggi M et al: Hypogonadal men who do not match the PDE5 -inbitor Tadalafil -Benefit in the normalization of the testosterone levels with a 1% Hydro alcoholic testostergel in the treatment of erectile dysfunction (TADT Test).J sex 2011;8: 284.

555. Shabsigh R, Kaufman JM, Steid c et al: Randomized study of testosterone gel as additional therapy for Sildenafil in hypogonadal men with erectile dysfunction that does not respond to sildenafil alone.J Urol 2004;172: 658.

556. Spitzer M, Basaria S, Travison TG et al: Effect of testosterone replacement on the response to sildenafilcitrate in men with erectile dysfunction: a parallel, randomized study.nan with 2012;157: 681.

557. Shamloul R, Ghanem H, Fahmy in et al: Testosterone therapy can improve the response of the erectile function to Sildenafil in patients with PADAM: a pilot study.J sex with 2005;2:559.

558. Kalinchenko Sy, Kozlov Gi, Gontcharov NP et al: Oral Testosterone Undecanoate runs erectile dysfunction associated with diabetes mellitus in patients who fail at Sildenafil Citrate -Therapy alone.6: 94.

559. Rosenthal BD, May Nr, Metro MJ et al: Dictant use of Androgel (testosterone gel) with sildenafil for the treatment of erectile dysfunction in men with acquired andrge -deficiency syndrome after failure using Sildenafil only.urology 2006;67: 571.

560. Yassin aa, saad f and dene: testosterone and erectile function in hypogonadal men do not respond to tadalafil: results of an open label uncontrolled study A Al: combined use of androgenic and sildenafil for hypogonadal patients not only responds to Sildenafil.18: 400.

562. Kim JW, OH MM, Park MG et al: Combination therapy of Testosterone Enanthat and Tadalafil on PDE5 inhibitor non-disputes with serious and intermediate testosterone deficiency.Thin J Impot Res 2013;25: 29.

563. Alhathal N, Elshal am and Carrier S: Synergetic effect of testosterone and Phophodesterase-5 inhibitors in hypogonadal men with erectile dysfunction: a systematic review.Can Urol Assoc J 2012;6: 269.

564. Corona G, Isiddori am, Buvat J et al: Testosterone supplement and gender: a Meta analysis study.J sex with 2014;11: 1577.

565. Bolona is, Uraga, etc., Haddad RM et al: Testosterone use in men with sexual dysfunction: a systematic review and meta analysis of randomized placebo -controlled studies.Mayo CLIN PROC 2007;82: 20.

566. Huo S, Scialli AR, McGarvey s et al: Treatment of men to "low testosterone:" A systematic review.Plos One 2016;11: E0162480.

567. Al-Gebari M, Jayasena CN, Mackeith P et al: Testosterone treatment for sexual dysfunction in men with type 2 diabetes: a systematic review and meta-analysis of randomized controlled experiment.35: 195.

568. Al-Juburi AZ and O'Donnell PD: Synergistic erection system: Clinical Experience.urology 1990;35: 304.

569. Aloui R, IWAZ J, Kokkidis MJ et al: a new vacuumerian as an alternative treatment of impotence.br J Urol 1992;70: 652.

570. Asopa R and Williams G: the use of the "correct" unit for controlling impotence.br J Urol 1989;63: 546.

571. Baltaci, Aydos K, Kosar a et al: Treatment of erectile dysfunction with a vacuumcensorcensor: a retrospective analysis of acceptance and satisfaction.BR J Urol 1995;76: 757.

572. Blackard CE, Borkkon WD, Lima JS et al: Use of vacuum tuma -censor to impotence secondary to venous leakage.urology 1993;41: 225.

573. Bosshardt RJ, Farwerk R, Sikora r et al: Objective measurement of efficiency, therapeutic success and dynamic mechanisms for the vacuum minterieur.br J Urol 1995;75: 786.

574. Broderick GA, Allen G and McClure RD: Vacuumtums Censor units: the role of Papaverin in the selection of patients.J Urol 1991;145: 284.

575. Cookson MS and NAME PW: Long -term results with vacuum housing unit.j Urol 1993;149: 290.

576. Derouet H, Caspari 500, Rohde 5 et al: Treatment of erectile dysfunction with external vacuum devices.Andrologia 1999;31Suppl 1: 89.

577. dutta tc an eid cf.54: 891.

578. Earle CM, Seah M, Canen See et al: The use of vacuum erection decor for dealing with erectile impotence.Int J Impot Res 1996;8: 237.

579. El-Bahrawy M, El-Baz Ma, Emam a et al: non-invasive vacuum limit determination for handling erectile dysfunction.Tint Urol Nephrol 1995;27: 331.

580. Gilbert HW and Gangell JC: Vacuum narrowing of devices: second -line conservative treatment of impotence.Br J Urol 1992;70: 81. 581. Gould Je, Switter DM, Broderick GA et al: External vacuum.Pharmacological erections.10: 68.

582. KAPLAN FJ, LEVITT NS, Stevens PJ et al: non-invasive management of organic Impotens.s AR with J 1995;85: 276.

583. Khayyamfar F, Forootan SK, Ghasemi H et: Evaluation of the effectiveness of vacuum -raised unity and causes of their failure with impotent patients.Ourol J 2013;10: 1072.

584. Kolettis PN, Lakin MM, Montague DK et al: Efficiency of the vacuum limitation unit in patients with corporal venous occlusive dysfunction.urology 1995;46: 856.

585. Korenman SG and Viosca SP: The use of a vacuum tummarycensor for dealing with impotence in men with a history of penis implant or severe pelvic disease.J am Geriatr SOC 1992;40: 61.

586. Cornman SG, Vosca SP, Kaiser Feet et al: Use a vacuum Tuesday decor to control impotence.J am Geriatr SOC 1990;38: 217.

587. Lewis RW and Witherington R: External vacuum therapy to erectile dysfunction: use and results.World J Urol 1997;15: 78.

588. Meinhardt W, Lycklama A Nijholt Aa, Bodyman RF et al: The negative printing to erectile dysfunction: when does it fail?149: 1285.

589. Moul JW and McLeod DG: negative pressure units in the explicit prosthetic population of the penis.J Urol 1989;142: 729.

590. Daadite PW, true JC and Blumoff R: Non-invasive unit to produce and maintain an erection-like state.Ourology 1986;27: 126.

591. OUTSER RJ, Wese Eg, they are coarse on et al: The external Vecuts device for handling erectile dysfunction.Acta UOL Belgian 1997;65: 13.

592. Segenreich E, Israel SR, Shmuelli J et al: Vacuum therapy combined with psychotherapy for dealing with various erectile dysfunction.EUR Urol 1995;28: 47.

593. Sidi aa, Becher EF, Zhang G et al: The acceptance and satisfaction of the patient with an external oppression unit to impotence. Urol 1990;144: 1154.

594. Sidi AA and Lewis JH: Clinical test with a simplified vacuum erection device for impotation treatment.urology 1992;39: 526.

595. Turner La, Althof SE, Levine SB et al: External vacuum decorations in the treatment of erectile dysfunction: a year of research into sexual and psychosocial impact.J Sex Marital Ther 1991;17: 81.

596. Turner La, Althof SE, Levine SB et al: Treatment of erectile dysfunction with external vacuum decorations: influence of sexual, psychological and marital function.J Urol 1990;144: 79.

597. From Thillo El and Delaere KP: vacuum erection unit.And non -vasive treatment of impotence.acta urol Belgian 1992;60: 9.

598. Villeneuve R, Corcos J ​​and Carmel M: assisted erection follow -Up with par.j sex marital ther 1991;17: 94.

599. Vrijhof HJ and Delaere KP: Vacuum replacement units in erectile dysfunction: acceptance and effectiveness in patients with impotence of organic or mixed Åtiology.br J Urol 1994;74: 102.

600. Willard Ba: an assessment of a vacuum limitation device for the treatment of erectile dysfunction.urol nurs 1998;18: 33.

603. Bodsansky HJ: Treatment of male erectile dysfunction with the help of the active vacuum assistant -set with 1994;11: 410.

604. Famuyiwa OO, al-Jasser SJ, Ahmad as an AL: experience with the vacuum-reinforced Tumescence Ereid system to treat erectile impotence in diabetes patients in Saudi Arabia.9: 141.

605. Israilov S, Shmuely J, NIV e et al: Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus.int J Impot res 2005;17: 431.

606. Pajovic B, Dimitrovski A, Fatic n et al: vacuum erection device in the treatment of organic erectile dysfunction and penile vasular differences between patients with type I and DM type II.20: 49.

607. Price de, Cooksy G, Jehu D et al: Handling of impotence in diabetic men in vacuum Tuesday therapy.8: 964.

608. Sun L, Money Fl, Yu Zl et al: Combined Sildenafil with vacuum erection Unity Unity Therapy for handling diabetic men with erectile dysfunction after failure in the first -line sildenafil monotherapy.int J Urol 2014;21: 1263.

609. Angel JD: Effect on the sexual function of a vacuum erection unit after prostatectomy.Can J Urol 2011;18: 5721.

610. Nason GJ, McNamara F, Twyford M et al: Efficiency of vacuum erectile units (ATS) after radical prostatectomy: the initial Irish experience of a dedicated by -Clinic.int J Impot Res 2016;6: 205.

611. Roina R, Agarwal A, Ausmundson s et al: Early use of vacuum restriction after radical prostatectomy facilitates early sexual activity and possibly previous return of erectile function.Int J Impot res 2006;18: 77.

612. Denil J, OHL DA and Smythe C: Vacuum erection unit of injured men of the spinal cord: patient and partner satisfaction.Arch Phys with Rehabil 1996;77: 750.

613. Nor L, Aloni r, turning o et al: vacuum tumor ripening therapy for neuropathic impotence.In J Adolesc with Health 1994;7: 255.

614. Lloyd Ee, Toth LL and Perkash I: Vacuum Tumscence: a chance for injured men with spinal cord with erectile dysfunction 1996;28: 235.

616. Watanabe t, Chancellor MB, Rivas da et al: Epidemiology of the current treatment of sexual dysfunction with men damaged by spinal cord in the American model of spinal cordscent centers.J Rugmeng with 1996;19: 186.

617. Zasler ND and Katz and: synergistic erection system for handling impotence secondary to spinal cord.Arch Phys with rehabilitation 1989;70: 712.

618. Chen J, Mabjesh NJ and Greenstein A: Sildenafil versus Vacuum Erection unit: Patient preferences.J Urol 2001;166: 1779.

619. Canven O, Bailen J, Fredriksson w et alj sex with 2009;6: 2561.

620. Kohler TS, Pedro R, Hendlin K et100: 858.

621. Brison D, Seftel A and Sadeghi-Nejad H: The revival of the vacuum erection unit (by) for the treatment of erectile dysfunction.Sex with 2013;10: 1124.

622. Padma-Nathan H, Hellstrom WJ, Kaiser Fe et al: Treatment of men with erectile dysfunction with transuretral alproadstadil.336: 1.

623. Williams G, Abbou CC, Amar and Ever Al: Efficiency and Security of Transurral Alprostadil Therapy in men with erectile dysfunction.Muse -TudieGruppe.br J Urol 1998;81: 889.

624. Shokeir Aa, Alsafi Ma and Mutabagani H: Intracanosal versus Intraurethral Alprostadil: a potential randomized study.Bju int 1999;83: 812.

625. Shabsigh R, Padma-Nathan H, Gittlalhan M et al: Intracavernous Alprostadil Alfadex is more effective, better tolerated and preferred instead of intraurethral alproadoTil Plus Optional Actis: a comparative, randomized, crossover, multicenter-studyie.urologie.urology;55: 109.

626. Chiang HS, Wen TC and Liang CF: Titration Study of Muse (Medical Urethra system for erection) in erectile dysfunction.J Formos with Assoc 2000;99: 926.

627. Ekman P, Sjogren L, Englund G et al: Optimization of the therapeutic approach of Transurradal alprostadil.bju Int 2000;86: 68.

628. Guay at, Perez JB, Velasquez e et al: Clinical experience with intraurethral Alprostadil (Muse) in the treatment of men with erectile dysfunction.A retrospective study.38: 671.

629. Jaffe JS, Antell MR, Greenstein M et al: Use of intraurethral Alprostadil in patients who do not respond to Sildenafil Citraat.urology 2004;63: 951.

630. Khan MA, Raistrick M, Mikhailidis DP et al: Muse: Clinical Experience.Curr With Res Opin 2002;18: 64.

631. Kim SC, AHN TY, Choi HK et al: multicenter study of the treatment of erectile dysfunction with transuretral alprostadil (Muse) in Korea.int J Impot res 2000;12: 97.

632. Kongkanand A, Ratana-Polarn K, Wuddhikarn s et al: Evaluation of Transurethale Alprostadilil for safety and efficiency in men with erectile disorders.J with Assoc Thai 2002;85: 223.

633. Mulhall JP, Jahoda AE, Ahmed a et al: Analysis of the consistency of intradral prostaglandin E1 (Muse) during Home.urology 2001;58: 262.

634. Garrido Abad P, Sinues Ojas B, Martinez Blazquez l et al: Safety and efficiency of intraurethral alproadstadil in patients with erectile dysfunction for treatment with the help of phosphodiesterase-5 inhibitors.actas urol ESP 2015;39: 635.

635. Pangkahila Wi: Evaluation of the transurethral use of Alprostadil to erectile dysfunction in Indonesian.asian J Androl 2000;2: 233.

636. Shabsigh R, Padma-Nathan H, Gittleman M et al: Intrakavernous Alprostadil Alfadex (Edex/Viridal) is effective and safe in patients with erectile dysfunction after failing Sildenafil (Viagra) .urology 2000;55: 477.

637. Hatzichristou DG, Apostolidis A, Tzortzis V et al: Sildenafil versus Intrakaverø's Injection therapy: Efficiency and preference in patients with intraca -neuze injection for more than 1 year.J Urol 2000;164: 1197.

638. Al-Juburi AZ and O'Donnell PD: Follow-up result of Intracaernous Papaverin.j Ark with SOC 1990;86: 383.

639. Alexandre B, Lemaire A, Desvaux P et al: Intrakavernosous injections of prostaglandin E1 to erectile dysfunction: satisfaction of the patient and the quality of sex life with long -term treatment.J sex with 2007;4:426.

640. Althof SE, Turner La, Levine SB et al: Injection of Intracaernosal in the treatment of impotence: a prospective study of sexual, psychological and marital function.J Sex Marital Ther 1987;13: 155.

641. Althof SE, Turner La, Levine SB et al: sexual, psychological and marriage effect of self -injection of papaverine and fentolamine: a long -term prospective study.J Sex Marital Ther 1991;17: 101.

642. Armstrong DK, Converse A and Dinsmore WW: intracanosal papaverine and fentolamine for medical treatment of erectile dysfunction in a urogenital clinic.Int J STD AIDS 1993;4: 214.

643. Armstrong DK, Converse A and Dinsmore WW: Prostaglandin E1 in medical control of erectile dysfunction in a genito urinary medical clinic.US with J 1994;63: 18.

644. Armstrong DK, Converse AG and Dinsmore WW: causes of patient increases from an intracanus car injection program to erectile dysfunction.br J Urol 1994;74: 99.

645. Bahren W, Scherb W, Gall H et al: Effects of intracaernosal pharmacotherapy on self -image, performance anxiety and partnership in patients with chronic erectile dysfunction.EUR UROL 1989;16: 175.

646. Baniel J, Israilov S, Engelsstein d et al: Three -year result of a progressive treatment program for erectile dysfunction with intraca -neuze injections of vasoactive drugs.urology 2000;56: 647.

647. Baum N, Randrup e, Junot d et al: Prostaglandine E1 versus gender therapy in the treatment of psychogenic erectile dysfunction.Int J Impot Res 2000;12: 191.

648. Bennett AH, carpenter AJ and Barada JH: an improved combination of vasoactive medicines for a pharmacological erection program.J Urol 1991;146: 1564.

649. Beretta G, Zanollo A, Ascani L et al: Prostaglandine E1 in the therapy of erectic deficit.Acta EUR Fertil 1989;20: 305.

650.149: 210.

651. Brock G, TU LM and Linen OI: Return or spontaneous erection under long -term Intracaernosal Alprostadil (Caverject) Treatment.urology 2001;57: 536.

652. Brown SL, Haas Ca, Koehler M et al: Hepatotoxicity related to the pharmacotherapy of Intrkavernø with Papaverin.urology 1998;52: 844.

653. Buvat J, Costa P, Morlier D et al: Double-blind multicenter research in which Alprostadil Alfa CyclodeXtrin is compared with Moxisiserchlorhydrate in patients with chronic erectile dysfunction.J Urol 1998;159: 116.

654. Buvat J, Lemaire A and Herbaut-Buvat M: Intracanuns Pharmacotherapy: comparison of Moxisylyte and Prostaglandin E1.Tht J Impot Res 1996;8: 41.

655. Canale D, Giorgi PM, Lencioni r et al: Long -term intraca -nosy self -injection with prostaglandin E1 for the treatment of erectile dysfunction.tin J Androl 1996;19: 28.

656. Casabe A, Bechara A, Cheliz G et al: Drop-out causes and complications of self-injection therapy with a triple vasoactive mixture of medicines in sexual erectile dysfunction.Int J Impot Res 1998;10: 5.

657. Chen J, Godschalk M, Katz Pg et al: The lowest effective dose of prostaglandin E1 as treatment of erectile dysfunction.J UROL 1995;153: 80.

658. Chen J, Godschalk MF, Katz Pg et al: Performance of penisms After the injection of a new formulation of prostaglandin E1.J UROL 1995;154: 77.

659. Chen RN, Lakin MM, Montague DK et al: Penile scars with intrakavernosous injection therapy with prostaglandin E1: a risk factor analysis.J Urol 1996;155: 138.

660. Chew KK, Stuckey BG, Earle CM et al: Penil -Fibrosis at Intracaernosal Prostaglandin E1 injection therapy for erectile dysfunction.Tin J Impot Res 1997;9: 225.

661191: 898.

662. Coombs PG, Heck M, Guhring P et al: An overview of the results of an Intracaernosal injection therapy program.Bju int 2012;110: 1787.

663. Cooper AJ: Evaluation of i-C-Papaverin in patients with psychogenic and organic impotence.Can J Psychiatry 1991;36: 574.

664. De la Taille A, Delmas V, Amar e et al: causes of failure of short and long-term self-injection therapy for Impotens.EUR Urol 1999;35: 312.

665. Dhabuwala CB, Kerkar P, Bhutwala a et al: Intrakavernous Papaverin in the treatment of psychogenic impotence.Arch Androl 1990;24: 185.

666. Dinsmore WW: Medical treatment of impotence with papaverine and fentolamine intracaernosal injection.Dulster with J 1990;59: 174.

667. Dinsmore WW, Gingell C, Hackett Get Al.BBB Int 1999;83: 274.

668. El-Sakka AI: Intracanosal prostaglandin E1 even versus office injection therapy in patients with erectile dysfunction.Int J Impot res 2006;18: 180.

669. Alprostadil's long -standing security (prostaglandin -e1) in patients with erectile dysfunction.The European Alprostadil -Study Group.br J Urol 1998;82: 538.

670. Flynn RJ and Williams G: Long -term order -Up of patients with erectile dysfunction started with self -injection with intracaernosal papaverine with or without Phentolamine.br J Urol 1996;78: 628.

671. Gall H, Sparwasser C, Bahren W et al: long -term results from Corpus Cavernosum Auto injection therapy for chronic erectile dysfunction.Andrologia 1992;24: 285.

672. Gerber GS and Levine LA: Pharmacological erection program with Prostaglandin E1.J UROL 1991;146: 786.

673. Gerstenberg TC, Metz P, Ottesen B et al: Intakaverneous self -injection with vasoactive intestinal polypeptide and fentolamine in the treatment of erectile failure.J Urol 1992;147: 1277.

674. Girdley FM, Bruskewitz RC, Feyzi J et al: Intrakavernø Self -injection for impotence: a long -term therapeutic option?140: 972.

675. Godschalk M, Gheorghiu D, Chen J et al: Long -term efficiency of a new formulation of prostaglandin E1 as treatment for erection failure.J Urol 1996;155: 915.

676. Godschalk MF, Chen J, Katz Pg et al: Prostaglandine E1 as treatment of erection failure in older men.J am Geriatr SOC 1994;42: 1263.

677. Godschalk MF, Chen J, Katz Pg et al: Treatment of erectile failure with prostaglandin E1: a Double Blind, placebo-controlled, dose-response test.J Urol 1994;151: 1530.

678. Govier Fe, McClure RD, Weissman RM et al: Experience with Triple-Medicament Therapy in a pharmacological erection program.J Urol 1993;150: 1822.

679. Gupta r, Kirschen J, Barrow RC et al: Predictors of success and risk factors for wear in the use of intraca -neuous injection.J Urol 1997;157: 1681.

680. Hattat H, Ozkara H, Accus e et al: Our experience with pharmacological erection treatment of erectile dysfunction.J Androl 1994;15Suppl: 47S.

681. Hauck EW, Altinkilic BM, Schroeder-Printzen in et al: Prostaglandine E1 Long-term self-injection program for the treatment of erectile dysfunction-a follow-up of at least 5 years.Andrologia 1999;31Suppl 1: 99.

682. HE L, Wen J, Jiang X et al: Long-term efficiency and safety of self-in-reasoning of prostaglandin E1 to treat erectile dysfunction in China.Enrologia 2011;43: 208.

683. Hirsch IH, SCHANNE FJ, CARSELO J et al: Sequential Penile -ultrasonic monitoring of patients treated with chronic intraca -neous prostaglandin E1.urology 1995;45: 1037.

684. Hollander JB, Gonzalez J and Norman T: patient satisfaction with the pharmacological erection program.Ourology 1992;39: 439.

685. HSIAO W, Bennett N, Guhring P et al: Satisfaction profiles in men who use intraka -nosal injection therapy.J Sex with 2011;8: 512.

686. Irwin MB and Kata not: high sliding speed with intrakavernosous injection of prostaglandin E1 for impotence.urology 1994;43: 84.

687. Ismail M, Abbott L and Hirsch IH: Experience with Intracaernous PGE-1 in the treatment of erectile dysfunction: dose considerations and efficiency.Tht J Impot Res 1997;9: 39.

688. Janosko EO: Intrakavernø self -injection of Popaverin and Regitin for the treatment of organic impotence.N C with J 1986;47: 305.

689. Kaplan SA, Reis RB, Kohn ij Al: Combination therapy with oral alpha -blockers and intracaernosal injection in men with erectile dysfunction.urology 1998;52: 739.

690. Kerfoot WW and Carson CC: Pharmacologically induced erections in geriatric men.J Urol 1991;146: 1022.

691. KHAN MM and KHWAJA M: Open label research of Intracaernous injection of Alpostadil Alphadex in the treatment of erectile dysfunction.Journal of Postgraduate Medical Institute 2005;19: 52.

692. Kirkeby HJ and Johannesen NL: Pharmacologically induced long -term erections produced by papaverine.frefring of Injection Therapy.scand J Urol Nephrol Suppl 1989;125: 97.

693. Kunelius P and Lukkarinen O: Intracavernous self -injection of prostaglandin E1 in the treatment of erectile dysfunction.Int J Impot Res 1999;11: 21.

694. Lakin MM, Montague DK, Water use meddorp s et al: injection -injection therapy of Intrakavernø: analysis of results and complications.J Urol 1990;143: 1138.

695. Lehmann K, Casella R, Blochlinger a et al: Causes of interrupting intraka -neuze injection therapy with prostaglandin E1 (Alprostadilil) .urology 1999;53: 397.

696. Levine SB, Althof SE, Turner La et al: Side effects of self -administration of Intracaernous Papaverine and Fentolamine for the treatment of impotence. Urol 1989;141: 54.

697. Linet OI and Ogrinc FG: Efficiency and security for intracanosal alproadstadil in men with erectile dysfunction.334: 873.

698. Willke RJ, Glick Ha, McCarron Tj et al: Quality of Life Effects of Alprostadil Therapy for erectile dysfunction.J UROL 1997;157: 2124.

699. Lloyd LK and Richards JS: Intracavernous pharmacotherapy for dealing with erectile dysfunction at spinal cord.ParaPlegia 1989;27: 457.

700. Lundberg L, Olsson Jo and Kihl B: Long -term experience with self -injection therapy with prostaglandin E1 to erectile dysfunction.Scand J Urol Nephrol 1996;30: 395.

703. Moemen MN, Hamed Ha, Camel, II et al: Clinical and sonographic assessment of the side effects of intraca -nosy injection of vasoactive substances.Thine J Impot res 2004;16:143.

704. Montorsi F, Guazzoni G, Bergamaschi f Al: Efficiency and safety of multidrug Intracneous therapy for vasculogenic impotence.urology 1993;42:554.

705. Montorsi F, Guazzoni G, Bergamaschi f Al: Intraca-neous therapy with four medicines for impotence as a result of corporal Veno-Octicive dysfunction.j Urol 1993;149:1291.

706. Mulhall JP, Jahoda AE, Cairney M et al: The causes of the Patient of Penis-Self-Evaluati therapy for impotence.J Urol 1999;162:1291.

707. Nellans Re, Ellis LR and Kramer-Levien D: Pharmacological erection: Diagnosis and treatment applications in 69 patients. Urol 1987;138:52.

708. Nelson RP: injections of Papaverin and Regitin into Corpora Cavernosa for erectile dysfunction: clinical results in 60 patients.ZOUTH with J 1989;82:26.

709.206:69.

710. Tilley, Louis GM, Cirrillo-Marucco E a one, one, one, one, one, one, one, one, one, one, a Tot long long-lasting vassiv intracavernous therapy.int j iPot Evenement 1996;8:63.

711. Perimenis P, Athanasopoulos A, Ramoutsos in et al: The occurrence of pharmacologically induced priapism in the diagnostic and therapeutic handling of 685 men with erectile dysfunction.urol int 2001;66:27.

712. Perimenis P, Gyftopoulos K, Athanasopoulos a et al: Diabetic impotence treated by intracaernosal injections: compliance with high treatment and increasing dosage of vaso-active medicines. Urol 2001;40:398.

713. VERY M, ROSENBERGER A, KAFTORI JK et al: Intracorporal calcification after self -injection of Papaverin.radiology 1990;176:81.

714. Porst H, Buvat J, Meuleman e et al: Intrakavernous Alprostadil Alfadex-a effective and well-tolerated treatment of erectile dysfunction.The results of a long -term European study.Int Jut J Impot Res 1998;10:225.

715. Porst H, Van Ahlen H, Block t et al: IntrakaNous itself injection of prostaglandin E1 in the therapy of erectile dysfunction.VASA Suppl 1989;28:50.

716. Puppo P, Rose of, Pittaluga P et al: Diagnosis of poor impotence after Intrakaernous Papaverin -Test.urol EUR 1988;15:213.

717. Purvis K, Egdetveit I and Christiansen E: Intracanosal therapy for erectile failure on treatment and reasons for apostasy and dissatisfaction.11:287.

718. Rabbani KJ, Tauqeer F and Rabbani R: Prostaglandin E1 for medical control over erectile dysfunction.Pack J with Health SCI 2010;4:512.

719. Robinette Ma and Moffat MJ: Intraoral injection of Papaverine and Fentolamine when dealing with impotence.br J Urol 1986;58:692.

720. Robinson PK: An observation study by Prostaglandine E1: comparison of experimental and maintenance dose.urol Nurs 1994;14:76.

721. Rowland DL, Buddhoe HS, Dohle G et al: Intracanosal self -injection therapy in men with erectile dysfunction: satisfaction and wear in 119 patients.11:145.

722. Ruutu M, Lindstrom BL, Virtanen J et al: Intrakavernø Self -injection for erectile failure.EUR UROL 1988;15:96.

723. Sandhu D, Curless E, Dean J et al: a double-blind, placebo-controlled study of intracaernosal vasoactive intestinal polypeptide and phenotolamine mesylyate in a new car injector for the treatment of non-psychogenic erection disorder function.11:91.

724. Schrameek P, Districts R, Waldhauser M et al: Prostaglandine E1 in erectile dysfunction.Copy and performance of priapism.br J Urol 1990;65:68.

725. Sexton WJ, Benedict JF and Jarow JP: comparison of long -term results from Penile prostheses and intracaernosal injection therapy.j urol 1998;159:811.

726. Shah PJ, Dinsmore W, Oakes Ra et al: Injection therapy to treat erectile dysfunction: a comparison between Alprostadil and a combination of vasoactive intestinal polypeptide and fentolamine -silat.curr with res Menspect 2007;23:2577.

727. SIDI AA, REDDY PK and CHEN KK: Acceptance and satisfaction of the patient with vasoactive intracaerte pharmacotherapy for impotence. Urol 1988;140:293.

728. Soderdahl DW, Thrasher JB and Hansberry KL: erection therapy induced by intracanosal medicines versus external vacuum devices in the treatment of erectile dysfunction.br J Urol 1997;79:952.

729. Sparwasser C, Drescher P, Breath Ra et al: long -term results of therapy with intracaernale injections and venous surgery in chronic erectile dysfunction.Scand J Urol Nephrol Suppl 1994;157:107.

730. Stackl W, Hasun R and Marberger M: Injection of Intrakaverø of Prostaglandin E1 at Impotent Men.J UROL 1988;140:66.

731. Stief CG, Gall H, Scherb W et al: Medium -term results of autonym therapy for erectile dysfunction.urology 1988;31:483.

732. Sundaram CP, Thomas W, Pryor le et al: Long -term follow -up of patients who receive injection therapy for erectile dysfunction.urology 1997;49:932.

733. Sung HH, AHN JS, Kim JJ et al: The role of intracaernosal injection therapy and the causes of withdrawal in therapy in patients with erectile dysfunction in PDE5 inhibitors in the era.Enrology 2014;2:45.

734. Throat A, Szekely J and Gotz F: Papaverine Induced erection.int Urol Nephrol 1989;21:195.

735. Turner La, Althof SE, Levine SB et al: Twelve months comparison of two treatments with erectile dysfunction: self -injection versus external vacuum decorations.urology 1992;39:139.

736. Turner La, Althof SE, Levine SB et al: Self -injection of Papaverine and Fentolamine in the treatment of psychogenic impotence.J Sex Marital Ther 1989;15:163.

737. Valdevenito R and Melman A: Intracanus Self Injection Pharmacotherapy Program: Analysis of results and complications.In J Impot Res 1994;6:81.

738. van der Windt F, Dohle GR, van der Dank J et al: Instakanosal Injection therapy with and without sexological counseling in men with erectile dysfunction.bju int 2002;89:901.

739. Virag R, Shoukry K, Floresco J et al: Intrakaernous self-injection of vasoactive drugs for the treatment of impotence: 8-year experience with 615 cases.J Urol 1991;145:287.

740. Watters GR, Keogh Not, Earle CM et al: Experience with dealing with erectile dysfunction with the help of intracaernosal self -injection of vasoactive drugs.j Urol 1988;140:1417.

741. Weidner W, Schroeder-Printzen I, Fischer C et al: Experience with the treatment of erectile dysfunction using intracaernosal self-injection of papaverine: results of a prospective study after a median follow-up of 42 months with 135 patients and 10766 injections.World J Urol 1992;10:179.

742. Weiss JN, Badlani GH, Ravalli r al: causes of high apostasy with self -injection therapy for impotence.Int J Impot Res 1994;6:171.

743. Williams G, Mulcahy MJ and KIILY EA: Impotence: Treatment by car injection of vasoactive medicines.BR with J (CLIN Resed) 1987;295:595.

744. Wu CC, XUE ZY, Apichat K etCLIN THER 1996;18:256.

745. Bell DS, Cutter GR, Hayne Vb et al: Factors that predict the effectiveness of fentolamine-papaerine intracorporal injection to treat erectile dysfunction in diabetic man.urology 1992;40:36.

746. Heaton JP, Lording D, Liu Sn et al: Intracanosal Alprostadil is effective in the treatment of erectile dysfunction in diabetic men.Tht J Impot Res 2001;13:317.

747. Montorsi F, Guazzoni G, Bergamaschi f Al: Clinical reliability of Intracaerte Vasoactive Pharmacotherapy with multiple drugs for diabetic impotence.Acta Diabetol 1994;31:1.

748. Perimenis P, Constantinopoulos A, Perimeni pp et al: Long -term treatment with intracaernosal injections in diabetic men with erectile dysfunction.Asian J Androl 2006;8:219.

749. Tsai YS, Lin JS and Lin YM: Security and efficiency of sterile powder from Alprostadil (p. Po., Caveject) in diabetes patients with erectile dysfunction.EUR UROL 2000;38:177.

750. Israirov S, NIV e, Livne PM et al: Intracavernosous injections with erectile dysfunction in patients with heart vessel diseases and failure or contraindications for sildenafil -citrate.int J Impot res 2002;14:38.

751. Albaugh Yes and Ferran's CE: Effect of Penile injections on men with erectile dysfunction after prostatectomie.urol Nurs 2010;30:64.

752. Claro JDE A, The Aboim Je, Maringolo M et al: Intrakavernosous injection in the treatment of erectile dysfunction after radical prostatectomy: an observation study.Sao Paulo with J 2001;119:135.

753. Dennis RL and McDougal WS: Pharmacological treatment of erectile dysfunction after radical prostatectomy.j urol 1988;139:775.

754. Domes T, Chung E, Deyoung L et al: Clinical results of Intracaernosal injection in patients after production: a single centrumer experience.Ourology 2012;79:150.

755. Gontero P, Fontana F, Babnasacco and All -Results from a hemodynamic prospective study.J Urol 2003;169:2166.

756. Montorsi F, Guazzoni G, Strambi lf et alj Urol 1997;158:1408.

757. Mydlo JH, Viterbo R en Cripen P: Gebruik van gecombineerde intracorporale injectie en een fosfodiesterase-5-remmertherapie voor mannen met een suboptimale respons op sildenafil en/of vardenafil monotherapie na radicale retropubische prostatectomie.BJU int 2005;95:843.

758. PraBhu V, Alukal JP, Lazy J et al: Long -term satisfaction and predictors for the use of intracorporal injections for erectile dysfunction after prostatectomy.j urol 2013;189:238.

759. Roina R, Lakin MM, Thukral M et al: Long -term efficiency and compliance with intracorporal (IC) injection with erectile dysfunction after radical prostatectomy: Shim (IIEF -5) analysis.Int J Impot Res 2003;15:318.

760. Yiou R, Bütow Z, Parisot J et al: Is it worthwhile to continue sexual rehabilitation after radical prostatectomy with intraka -neuze injection of Alprostadil for more than 1 year?3:42.

761. Yiou R, Cunin P, De la Taill a et al: Sexual rehabilitation and penisms arrived in intracavernous Alpostadil after radial prostatectomi.j sex with 2011;8:575.

762. Mansi MK, Alkhudair World Cup and Huraibs: Treatment of erectile dysfunction after kidney transplantation with intracanosal self -injection of prostaglandin E1.J UROL 1998;159:1927.

763. Beretta G, Zanollo A, Fanciullacci f al: Intrakavernosous injection of parapegical men.Acta EUR Fertil 1986;17:283.

764. Bodner DR, Leffler B and Frost F: The role of intraca -nosy injection of vasoactive medicine for recovery of erection in injured men of the spinal cord: a order of three -year -old parapegia 1992;30:118.

765. Chao R and Clowers The: experience with Intracaernosal Tri-Blend for handling neurogenic erectile dysfunction.Arch Phys with rehabilitation 1994;75:276.

766. Earle CM, Keogh Not, Ker Jk et al: The role of intracaernosal vasoactive agents to overcome impotence as a result of spinal cord.ParaPlegia 1992;30:273.

767. HIRSCH IH, Smith RL, Chancellor MB et al: Use of intraca -nosy injection of prostaglandin E1 to neuropathic erectile dysfunction.ParaPlegia 1994;32:661.

768. Kapoor vk, Chahal As, Jyoti sp et al: Intrakavernous Papaverin for impotence in patients with spinal cord.31:675.

769. SIDI AA, Cameron JS, Dykstra Dd et al: Vasoactive intraka pharmaceutical pharmacotherapy to treat erectile impotence in men with spinal cord.J Urol 1987;138:539.

770. Tang SF, CHU NK and WONG MK: Intrakavernous injection of prostaglandin E1 in injured patients with spinal cord with erectile dysfunction.A provisional report.ParaPlegia 1995;33:731.

771. ZASLAU S, Nicolis C, Galea G et al: A simplified pharmacological erection program for patients with spinal cord.J -Ridgemeng with 1999;22:303.

772. Derouet H, MeetH M and Bewermeier H: Experience with a Papaverine/Phentolamine/Prostaglandin E1 mixture in non-respondation on Autoinjektionterapia.5: 271.

773. Akdemir F, Okulu E and Kayigil O: Long -term results from AMS Spectra® Penile Protesimean implantation and satisfaction percentage.5:184.

774. CASABE AR, SAROTTO N, GUTIERREZ C et al: Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models.Int J Impot Res 2016;28:228.

775. Akin Olugbade O, Parker M, Guhring P et al: Determinants of patient satisfaction after the operation of penis prosthesis.J sex with 2006;3:743.

776. Al-Najar A, Naumann cm, Kaufmann s et al: Should the age of more than 70 years of obstructing the implantation of penis?104:834.

777. Altunkol A, Erçil H, şener NC et al: Clinical evaluation of results from Penis prosthesimesis and partner satisfaction.Ciye's Tip Daisi 2014;36:148.

778. Anafarta K, Safak M, Beduk y et al: Clinical experience with inflatable and fungal penil implants in 104 patients.urol int 1996;56:100.

779. Bae JH, Song PH, Kim HT et al: Assessment of erectile and ejacul*tion function after implantation of penis prosthesis.Korean J Urol 2010;51:202.

780. Bettocchi C, Palumbo F, Spilotros M et al: Patient and partner satisfaction after AMS -inflatable penis -prosthesis.j sex with 2010;7:304.

781. Borges F, Hakim L and Kline C: Surgical technology to maintain Pen -length after inserting an inflatable Penile prosthesis via infrapubic approach.j sex with 2006;3:550.

782. Bozkurt IH, Arslan B, Kozacioglu z et al.baihsiung j med sci 2014;30:570.

783. Bozkurt IH, Arslan B, Yonguc t et al: Patient and partner result of inflatable and semi-Kingdom Penil prosthesis in a single institution.In Braz J Urol 2015;41:535.

784. Brinkman MJ, Henry GD, Wilson SK et al: A study in patients with inflatable Penile prostheses for satisfaction.J Urol 2005;174:253.

785. Cakan M, Demirel F, Karabacak O et al: Risk factors for Protetical Infection of the Penis.Tint Urol Nephrol 2003;35:209.

786. Carson CC, Mulcahy JJ and Govier Fe: Efficiency, security and patient satisfaction results from AMS 700CX inputable Penis Prosthesis: Results of a long-term multicenter-survey.ams 700CX Study Group.j Urol 2000;164:376.

787. Carson CC 3RD, Mulcahy JJ and Harsch MR: Long-term infection results after original antibiotic impregnated inflatable penile Protesimesis: up to 7.7 years Follow-up.j Urol 2011;185:614.

788. Carvalheira A, Santana R and Pereira NM: Why are men satisfied or dissatisfied with penis implants?12:2474.

789. Chiang HS, Liao CH and Chang ML: The benefits of antibiotic -inceginated inflatable Penile prosthesis (Remmizone®) in patients with a high risk of infection in Taiwan.urological Science 2016;27:144.

790. Chiang HS, WU CC and Wen TC: 10 years of experience with Penile prosthesis implant in Taiwanese patients.J Urol 2000;163:476.

791122:402.

792. dent Choi Y, Jin Choi Y, Hwan Kim J et al: Mechanical reliability of AMS 700CXM Inflatable Penile Prosthesis for the treatment of male erectile dysfunction.J Urol 2001;165:822.

793. Chung E, Solomon M, Deyoung L et al: Clinical results and patient satisfaction in older male ages ≥75 years with inflatable penis prosthesis for medical refractory erectile dysfunction.World J Urol 2013;1:173.

794. Chung E, Van CT, Wilson in et al: Penile -Prosthetic implantation for the treatment of male erectile dysfunction: clinical results and experiences after 955 procedures.World J Urol 2013;31:591.

795. Daich yes, Angermer KW, Lakin mm et al: Long-term mechanical reliability of AMS 700 series Inflatable Penis Protese: comparison of CX/CXM and Ultrex-cylinders.j Urol 1997;158:1400.

796. Dhabuwala C, Sheth S and ZamZow B: infectious percentages for iFampin/Gentamicin-Coate Titan Coloplast Penil implants.The comparison with AMS-Pen implants impregnated by Remmizon.J Sex with 2011;8:315.

797. DHAR NB, Angermeier KW and Montague DK: Long -term mechanical reliability of AMS 700CX/CXM inflatable Penile prosthesis.j Urol 2006;176:2599.

798. Dorflinger T en Bruskewitz R: Ams Moldable Penile Prenhese.urology 1986;28:480.

799. Droggin D, Shabsigh R and Anastasiadis AG: Antibiotic coating reduces the infection of the penis prosthesis.J sex with 2005;2:565.

800. Earle CM, Watters GR, Tulloch Ag et al: Complications associated with penis implants used to treat impotence.Aust n Z J Surg 1989;59:959.

803.Fathi A, Shamlh R, Abdul Rahim A. Al: Rfarning Top (Bromide) is sprayed in the Nile of Ambalana.79:244.

804. Fein RL: GFS Mark II Inflatable Penile prosthesis: Vierjarige Clinical Study 1994;43:209.

805.61:437.

806. Furlow WL, Goldwasser B and Gundian JC: Implantation of model AMS 700 Penile prosthesis: Long-term results.J UROL 1988;139:741.

807. Knoll LD, Furlow WL and Motley RC: Clinical Experience Implants An inflatable Penile prosthesis with cylinder of controlled expansie.urology 1990;36:502.

808. Garber BB and Marcus SM: influences the surgical approach to the occurrence of infection with inflatable penis prosthesis?Urology 1998;52:291.

809. Garber BB: Inflatable Penile prosthesis: results of 150 cases.BR J Urol 1996;78:933.

810. GARBER BB: AUTORITY inflatable insertion of penisprothesis.urology 1997;49:600. 811. Garber bb: inflatable penile prosthesis: place -specific functional analysis.Int J Impot Res 2003;15:22.

812. Gentile G, Franceschelli A, Massenio P et al: The satisfaction of the patient after 2-part inflatable penis prosthesis: an Italian multicentric study.Arch Ital Urol Androl 2016;88:1.

813. Goldstein I, Bertero Eb, Kaufman JM et al: Early experience with the first pre-associated 3-part inflatable penis prosthesis: Mentor Alpha-1.j Urol 1993;150:1814.

814. Goldstein I, Newman L, Baum n et al: security and efficiency Result by mentor Alfa-1 inflatable Penile prosthesis for impotence treatment.J UROL 1997;157:833.

815. Grewal S, Vetter J, Brandes SB et al: a population -based analysis of modern re -operation percentages for Penis Proses Procedures.urology 2014;84:112.

816. Henry GD, Brinkman MJ, Mead SF et alj Sex Med 2012;9:1715.

817. Henry GD, Carrion R, Jennermann c et al: Prospective evaluation of postoperative penishabilitation: Maintenance of penis length/Omber 1 year after Coloplast Titan Inflatable Penile prosthesis.j sex with 2015;12:1298.

818. Hollenbeck BK, Miller DC and OHL DA: the tool of Lockout -valves reservoirs to prevent car inflation in Penile prostheses.Int Urol Nephrol 2002;34:379.

819. Holloway FB and Farah RN: Intermediate determination assessment of reliability, function and patient satisfaction with the AMS700 Ultrex Penile protesis.j Urol 1997;157:1687.

820. Jarow JP: Risk factors for Penil Protetical Infection.j Urol 1996;156:402.

821. Jensen JB, Larsen eh, Kirkeby HJ et al: Clinical experience with mentor Alpha-1 Inflatable Penile PROPHESE: report on 65 patients.Scand J Urol Nephrol 2005;39:69.

822. Jensen JB, Madsen SS, Larsen eh et al: Patient and partner satisfaction with mentor Alpha-1 inflatable Penile prosthesis.scand J Urol Nephrol 2005;39:66.

823. Ji ys, KO YH, Song Ph et al: Long -term survival and patient satisfaction with inflatable Penile prosthesis for the treatment of erectile dysfunction.Korean J Urol 2015;56:461.

824. Kilicarslan H, Kaynak Y, Gokcen K et al: Comparison of patient satisfaction speeds for the formable and two pieces of Penile prostheses attached.Turk J Urol 2014;40:207.

825. KIM DS, Yang KM, Chung HJ et al: AMS 700CX/CXM Inflatable Penile Prosthesis has a high mechanical reliability of long -term order -up.j sex with 2010;7:2602.

826. Kucuk EV, Tahra A, Bindayi a et al: Patients with erectile dysfunction are more satisfied with the implantation of penis prosthesis compared to Tadalafil and intracaernosal injection treatments.Andrology 2016;4: 952.

827. Lacy J, Walker J, Gupta s et al: Risk factors for removal or revision of penile prostheses in veteran population.Ourology 2016;98: 189.

828. Levine LA, Estrada CR and Morning Palace A: Mechanical reliability and safety and patient satisfaction with ambicor inflatable penis prosthesis: results of a survey with 2 -center.j urol 2001;166:932.

829. Liberman SN, Gomella LG and Hirsch IH: experience with Ultrex and Ultrex Plus inflatable penis prosthesis: new implant techniques and surgical results.10:175.

830. Lin an: Implantation of Penil prosthesis: Clinical experience with 105 cases.Asian J Surg 1989;12:125.

831. Lindeborg L, Fode M, Fahrenkrug L et al: Satisfaction and complications with Titan® One-Touch Release Penilimplant.scand J Urol 2014;48:105.

832. LLLLLEDO-GARCIA E, JARA-RRACON J, Moncada Iribren in et al: Penile prosthesis First and replacement surgery: Analysis of patient and partner's satisfaction.J sex with 2015;12:1646.

833. Lotan Y, Roehrborn CG, McConnell JD et al: Factors that influence the results of Penis -Protesis surgery in an educational institution.Ourology 2003;62:918.

834. Lubensky JD: outpatient clinic 3-part inflatable penis prostheses.j urol 1991;145:1176.

835. Lux M, Reyes-Vallejo L, Morning Talks a et al: Results and satisfaction percentages for the redesigned 2-part Penile prosthesis.J Urol 2007;177:262.

836. Lynch MJ, Scott GM, Inglis Yes et al: Reduction of the loss of implants after penisal surgery.br J Urol 1994;73:423.

837. Malloy TR, Wein AJ and Carpiniello VL: Reliability of AMS 700 Inflatable Penile Protheses.urology 1986;28:385.

838. Manning M, Martinez FJ, Alken P et al: Spontaneous tumescence after implantation of three -part hydraulic penile prostheses: a short -term experience.Tht J Impot Res 2003;15:152.

839. Mansi MK: Penile Prothesis: Long-term follow-up.Saudi with J 1996;17:365.

840. McLaren RH and Barrett DM: Patient and partner satisfaction with AMS 700 Penile -Prosthesis.j Urol 1992;147:62.

841. Merrill DC: Clinical experience with mentoring Petable Penile prosthesis in 301 patients.J UROL 1988;140:1424.

842. Milbank in, Montague DK, Angermeier KW et alj Urol 2002;167:2502.

843. Minervini A, Ralph DJ and Pryor JP: The result of cash prosthesis implantation for the treatment of erectile dysfunction: experience with 504 procedures.bju int 2006;97:129.

844. Miranda-sousa A, Keating M, Moreira s et al: simultaneous ventral falloplasty during Penil implant surgery: a new procedure that optimizes the satisfaction of the patient and their perception of fallic length for penis implant surgery.j sex with 2007;4:1494.

845. Mirheydar H, Zhou t, Chang DC et al: Restoration percentages for penisprothetical surgery.j sex with 2016;13:129.

846. Moncada I, Martinez-Salamanca Ji, Jara J et al: Inflatable Penisprothetical impedation without corporal dilatation: a cavernous tissue saving technique.j urol 2010;183:1123.

847. Montorsi F, Rigatti P, Carmignani G et al: AMS-Voorde Inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients.EUR UROL 2000;37:50.

848. Gittens P, Moskovic DJ, Avila D, Jr.et Al: favorable sexual function for women is associated with the satisfaction of the patient after inflatable penis prosthesimesis.j sex with 2011;8:1996.

849. Moul JW and McLeod DG: Experience with AMS 600 mentioned Penile Protheses.j Urol 1986;135:929.

850. Mulhall JP, Ahmed A, Branch J et al: Serial assessment of efficiency and satisfaction profiles after an operation of Penisprotheses.j Urol 2003;169:1429.

851. Natali A, Olianas R and Fisch M: Penil implant in Europe: Successes and complications with 253 implants in Italy and Germany.5:1503.

852. Negro CL, Paradiso M, Rocca a et al: Implantation of AMS 700 LGX Penile prosthesis retains the length of the penis without the need for Penile Extension Procedures.asian J Androl 2016;18:114.

853. Nickas Me, Kessler R and Kabalin JN: Long -term experience with controlled expansion cylinders in AMS 700CX inflatable Penile prosthesis and comparison with previous versions of Scott inflatable Penile Protheses.urology 1994;44:400.

854. Nukui f, okamotos, nagata with al: complications and re -implantation of penile implants.The J Urol 1997;4:52.

855. OHL DA, Brock G, Ralph D et al: Prospective evaluation of patient satisfaction and surgeon and patient training Assessment of Coloplast Titan One Touch Refresh of three -part inflatable Penile prosthesis.J sex with 2012;9:2467.

856. Paranhos m, Andrade E, Antunes AA et al: Penile -Protese Implantation 1 in Akademisk Institution 1 Latinamerika.int Braz J Urol 2010;36:591.

857. Vissers en, alei g, Antoni g t al: increaseed: Italian Society of Andrology Registry on Penile Issa Chirurgie.Første Dataanalyse.Rch Ital Uol Androl 2016;88:122.

858. Pozza D, Pozza M, Musy M et al: 500 Penile prostheses implanted by a surgeon in Italy during the past 30 years.Arch Ital Urol Androl 2015;87:216. 859. Randrup is: Clinical experience with 180 inflatable Penile prostheses.south with J 1995;88:47.

860. Randrup e, Wilson S, Mobley D et al: Clinical experience with Mentor Alpha in inflatable Penile prosthesis.Report on 333 cases.urology 1993;42:305.

861. Rogers E and Murphy DM: with the help of AMS -unimpedly Penile prosthesis for dealing with erectile impotence.ir with J 1997;90:105.

862. Salama N: Satisfaction with the formable Penile prosthesis between couples from the Middle East-Anders than the reported elsewhere in Impot Res 2004;16:175.

863. Salem et al., Wilson SK, NEEB A ET Al: Mechanical reliability of AMS 700 CX improved by PARYLEN Paving.J Sex with 2009;6:2615.

864. SAYPOP DC, Uhran CM and Stockman JC: Treatment of erectile failure with inflatable dentures: three years of experience.N J with 1987;84:191.

865. Scarzella GI: Reliability of AMS inflatable dentures in 444 consecutive cases.Arch Ital Urol Androl 1993;65:661.

866. Scarzella Gi: cylinder -profitability of inflatable Penile prosthesis.31:486.

867. Sereefoglu EC, Mandava SH, Gokce a et al: Long-term audit speed as a result of infection in hydrophilic supply of inflatable penis prostheses: 11-year-old follow-up.j sex with 2012;9:2182.

868. Sevinc C, Ozkaptan O, Balaban M et al: Result of Penis -prosthesis Implantation: are his formable dentures A suitable treatment option in patients with erectile dysfunction caused by earlier radical surgery?4: 477.

869. Simsek A, Kucukukutopcu o, Ozgor f et al: Self and partner satisfaction rates after 3 -part inflatable Penil Proteseimesis.arch Ital Urol Androl 2014;86:219.

870. Song WD, Yuan YM, CUI WS et al: Penile Prothetic implantation in Chinese patients with severe erectile dysfunction: 10-year experience.Asian J Androl 2013;15:658.

871. Tefilli, etc., DuboCQ F, Rajpurkar a et al: Assessment of psychosexual adjustment after introducing inflatable Penile prosthesis.urology 1998;52:1106.

872. Thomas AZ, Carrol R, Manecksha RP et al: Extensive functional results in the long term of inflatable Penile prosthesis in a single institution.IR with J 2011;104:53.

873. Vak alopoulos I, Kampantais S, Ioannidis s et al: High satisfaction of the patient after inflatable penile prostheses implant correlates with female partner satisfaction.J sex with 2013;10:2774.

874. Vitarelli A, Davenuto L, Fortunato f et al: Long -term patient satisfaction and quality of life with AMS700CX Inflatable Penile Prostheses.arch Ital Urol Androl 2013;85:133.

875. The Whale RK and Merrill DC: Patient satisfaction with supervising Petable Penile Protheses.urology 1991;37:531.

876.wilson SK and Delk JR, 2nd: Inflatable Penil implant Infection: Predisputing factors and treatment suggestions.J Urol 1995;153:659.

877. Wilson SK, Carson CC, Cleves Ma et al: quantification of the risk of penis prosthesis infection with raised glycosylated hemoglobin.j urol 1998;159:1537.

878. Wilson SK, Cleves Ma and Delk Jr 2nd: comparison of the mechanical reliability of original and improved mentor Alpha in Penile -Prosthesis.j Urol 1999;162:715.

879. Wilson SK, Delk JR, Salem et al: Long -term survival of inflatable Penile prostheses: experience with a single surgical group with 2,384 implants in the first time that include two decades.J sex with 2007;4:1074.

880. Woodworth Be, Carson CC and Webster GD: Inflatable penis prosthesis: Effect of device adjustment on Functional Life.urology 1991;38:533.

881. Zabar KJ, Ahmadi A and Jalal Aa: Penile -Protersis implantation to treat erectile dysfunction.Bahrain Medical Bulletin 2009;31:2.

882. ZHU YC, ZHAO JL, WU YG et al: Clinical characteristics and treatment options for Chinese patients with severe primary erectile dysfunction.urology 2010;76:387.

883. Antonini G, Busetto GM, the Berardinis e et al: Penile Professors to erectile dysfunction: a new minimal invasive infrapubic surgical technique.Arch Ital Urol Androl 2015;87:322.

884. Menard J, Tremeaux JC, Faix a et al: Erectile function and sexual satisfaction before and after Penile prosthesis implantation for radical prostatectomie patients: a comparison with patients with vasculogenic erectile dysfunction.J sex with 2011;8:3479.

885. Kim Yd, Yang So, Lee Jk et al: Utility of a Formable Penile prosthesis in patients with spinal cord.The J Urol 2008;15:919.

886. Kramer AC and Schweber A: The expectations of the patient before Coloplast Titan Penile Prosthesis Implanting predicts post -operative satisfaction.J sex with 2010;7:2261.

887. Nehra A, Carson CC 3RD, Chapin Ak et al: Long-term infection results of three-part antibiotics impregnated Penile prostheses used for compensation implant surgery.J Urol 2012;188:899.

888. Mulcahy JJ and CARSON CC 3: Long-term infections in diabetes patients implanted with antibiotic-impregnated versus non-impregnated inflatable penis prostheses: 7-year results. Urol 2011;60:167.

889. Christodoulidou M and Pearce I: infection of Penile Protese in patients with diabetes mellitus.-Church Infect (Larchmt) 2016;17:2.

890. DEVECIs, Martin D, Parker M et al: Change of pen length after operation in Penile prosthesis.EUR Urol 2007;51:1128.

891. Wang R, Howard Ge, Hoang et Alasian J Androl 2009;11:411.

892. Levine LA and Rybak J: Traction therapy for men with a shortened penis before implantation of penis prosthesis: a pilot study.J sex with 2011;8:2112.

893. CANGUAGE O, Talib RA, Campbell J et al: Is the daily use of vacuum erection decoration a month before penis prosthesis implantation?5:103.

894. Pahlajani G, Raina R, Jones s et al: Vacuum erection device Review: The new role in the treatment of erectile dysfunction and early Penilrehabilitation after prostate therapy.j sex with 2012;9:1182.

895. Tsambarlis PN, Chaus F and Levine LA: Successful placement of Penile prostheses in men with severe corporal fibrosis after vacuum therapy protocol.j sex with 2017;14:44.

896. Henry GD, Kansal NS, Callaway M et al: Centers of Excellence Concept and Penis Protesis: a result analysis.j Urol 2009;181:1264.

897. Hakky TS, Suber J, Henry G et al: Penile improvement procedures with a simultaneous location of penis prosthesis.Advrol 2012;2012:doi: 10.1155/2012/114612.

898. Chew KK and Stuckey BG: With the help of Transurral Alprostadil (Muse) (prostaglandin E1) to shine tumes of a patient with Penile prosthesis.Int J Impot Res 2000;12:195.

899. Benevides MD and Carson CC: Intradrethral use of Alprostadil in patients with a failed inflatable Penile prosthesis.J UROL 2000;163:785.

900. Mulhall JP, Jahoda A, Aviv n et al: The effect of sildenafilcitrate on sexual satisfaction profiles in men with a penis prosthesis in situbju int 2004;93:97.

901018:754.

902. Anafarta K, Aydos K ​​and Yaman O: Is deep dorsal venerialization an alternative surgical approach to treatment of venogenic impotence?59:109.

903. Austoni e, Colombo F, Mantovani f all: Venous surgery in erectile dysfunction: therapeutic strategy and results.Ourol Int 1992;49:63.

904. Balko A, Malhotra CM and Wincze JP: Deep Penile-Vein-Arterialization for arterial and venous impotence.Arch Surg 1986;121:774.

905. Cookson MS, Phillips DL, Huff Me et al: Analysis of microsurgical Penile Rascularization results in Ethiology of Impotence. Urol 1993;149:1308.

906. CRESPO E, BOVE D, FARRELL GE EL: Revascularization of the caverneous body in vasculogenic sexual male impotence with a new microsurgical technique.Cardiovasc is residing Bull 1983;22:29.

907. Depalma RG, Olding M, Yu Gw et al: Vascular interventions for impotence: experiences.J Vasc Surg 1995;21:576.

908. Frankovicova M and Thoma A: Microvascular treatment of impotence.Plast reconster Surg 1993;91:99.

909. Grasso M, Lania C, Castelli M et al: Deep dorsal venous arterialization by vasculogenic impotence: our experience.arch Ital Urol Nephrol Androl 1992;64:309.

910. Hatzinger M, Seemann O, Grenacher L et al: Laparoscopy-assisted Penilre Vascularization: a new method.J Endourol 1997;11:269.

911. Janssen T, Sarramon JP, Rischmann p et al: microsurgical arterio arterial and arterio-venous peniswassy in patients with pure arteriogenic impotence.br J Urol 1994;73:561.

912. Jarow JP and Defranzo AJ: long-term results of arterial bypass surgery for the secondary impotence of segmental vascular diseases.J Urol 1996;156:982.

913. Kaufman JM, Kaufman JL and Fitch WP 3 .: Deep dorsal digialization in arteriogenic impotence: Use of the dorsal arthy as a neo -Ror. In J Impot res 1995;7:157.

914. Kawanishi y, Kimura K, Nakanishi r al: Penile replacement Surgery for arteriogenic erectile dysfunction: long-term efficiency calculated by survival analysis.bju int 2004;94:361.

915. Kayigil o, Agras K and Okulu e: Is deep dorsal venerararianization effective in older patients?40:125.

916. Kayigil O, Ahmed Si and Metin A: Deep dorsal venerararianization in pure caverno -clocking dysfunction.EUR UROL 2000;37:345.

917. Kayigil o, Okulu e, Aldemir m et al: Penile rescheduling in vascular erectile dysfunction (ED): Long-term follow-up.bju int 2012;109:109.

918. Knoll LD: Penile dorsal venerararianization when dealing with venogenic impotens.tech urol 1995;1:157.

919. Lizza EF and Zorganiotti AW: experience with the long-term effect of microsurgical Penil replacement.Int J Impot Res 1994;6:145.

920. Lobelenz M, Junemann KP, Kohrmann Ku et al: Penile Rascularization in Non -answer to intracaerte injections using a modified microsurgical technique.EUR Urol 1992;21:120.

921. Lukkarinen O, Tonttila P, Hellstrom P et al: Non-protection surgery in the treatment of erectile dysfunction.32:42.

922. Manning M, Junemann KP, Scheeepe Jr et al: Long-term follow-up and selection criteria for penile replacement by erectile failure.j urol 1998;160:1680.

923. Melman A and Riccardi R, Jr.: The success of microsurgical penis Rinkularization to treat arteriogenic impotence.Int J Impot Res 1993;5:47.

924. Michal V, Kramar R, Postpichal J et al: Arterial epigastricocaverneous anastomosis for the treatment of sexual impotence.World J Surg 1977;1:515.

925. Munarriz R, Uberoi J, Fantini G et al: Microvascular arterial bypass surgery: Long-term results using validated instruments.j Urol 2009;182:643.

926. Sarramon JP, Bertrand N, Malavaud B et al: Micro -Washing of penis in vascular impotence.Int J Impot Res 1997;9:127.

927. Sarramon JP, Malavaud B, Braud f et al: Evaluation of the sexual function of the international index of erectile function after deep dorsal venous arterialization of penis.j urol 2001;166:576.

928. Schrameek P, Engelmann U and Kaufmann F: Microsurgical arteriovous revascularization in the treatment of vasculogenic impotence.J Urol 1992;147:1028.

929. Sohn M, Sikora R, Bohndorf K et al: Selective microsurgery in arteriogenic erection failure.World J Urol 1990;8:104.

930. Vardi Y, Gruenwald I, Gedalia U et al: Evaluation of Penile repair cularization for erectile dysfunction: a 10-year follow-up.tin J Impot res 2004;16:181.

931. Virag R and Bennett AH: Arterial and venous surgery for vasculogenic impotence: a combined French and American experience.Arch Ital Urol Nephrol Androl 1991;63:95.

932. Wespes E, Corbusier A, Delcour C et al: deep dorsal worship in vascular impotence.Br J Urol 1989;64:535.

933. Wespes E, Wildschutz t, Roumegue t et al: The surgical place of vascular impotence in the third millennium.j urol 2003;170:1284.

934. Zumbe J, Drawz G, Wiedemann a et al: Indications of Penile-Crechamization and long-term results.Andrologia 1999;31 Suppl 1:83.

935. Munarriz R: Penile Microvascular arterial bypass surgery: indications, results and complications.Scientific World Journal 2010;10:1556.

936. Dabaja AA, counting P and Mulhall JP: a critical analysis of candidacy for revascularization of the penis.j sex with 2014;11:2327.

937. Afsar H, Metin A, Sozduyar n et al: erectile disorders due to venous incompetence treated by Backs.t Urol Nephrol 1992;24:65.

938. Anafarta K, Beduk Y, Aydos K ​​et al: Treatment of impotence as a result of venous leakage due to resection of the deep dorsal vein in Penis.urol Int 1992;48:332.

939. Bar-Moshe O and Waterdish M: Surgical approach of venous leakage.urol int 1992;49:19.

90.47:88.

941. Cakan M, Yalcinkaya F, Demirel f et al: Is Dorsal Penile Vein League (DPVL) still a treatment option in VENO-OCCLUCLIVE DIFUTION?36:381.

942. Cayan S: Primary Penile -Closing Operation with Crural League in men with erectile dysfunction.J Urol 2008;180:1056.

943. Chen SC, HSIEH CH, HSU GL ET AL: The progression of the penis friend: can it return? J Androl 2005;26:53.

944. Claes H and Baert L: Pelvic floor exercise versus surgery in the treatment of impotence.br J Urol 1993;71:52.

945. Claro JDE A, De Lima ML and Net Junior N: Surgical treatment of Veno-O-o-occlusive dysfunction: Evaluation of short-term and long-term results.Rev Paul with 1992;110:280.

946. Flores S, Tal R, O'Brien K et al: Results of the Surgery of the Crural League for isolated venous leakage.8:3495.

947. Fowlis GA, SIDHU PS, HRUUGE Mr et al: Provisional report-combined surgical and radiological penis occlusion for dealing with impotence caused by venous sine-sinusoidal incompetence.br J Urol 1994;74:492.

948. Freedman Al, Costa Neto F, Mehringer CM et al: Long -term results of penis comparison for impotence from venous leakage.J Urol 1993;149:1301.

949. Gilbert P, Sparwasser C, Beckert r et al: venous surgery in erectile dysfunction. The role of dorsal-penile feed in litter and spongiosolysis for impotence.urol int 1992;49:40.

950. Hassan AA, Hassouna MM and Elhilali etc.: long -term results of the venous competition for corporal venous occlud -disfunction.can J Surg 1995;38:537.

9511150:1810.

952. HSU GL, CHEN HS, HSIEH CHT AL: Clinical experience with a refined penis venous comic surgical procedure for patients with erectile dysfunction: is it a feasible option? J Androl 2010;31:271.

953. Hwang Ti and Yang CR: Penile vein such as Venogenic Impotens.EUR Urol 1994;26:46.

954. Katzenwadel A, Popken G and Wetterauer U: Penile Veneous Surgery for Cavernosal Venous Leakage: Long -term results and retrospective Studies.urol Int 1993;50:71.

955. Kerfoot WW, Carson CC, Donaldson JT et al: Study of vascular changes after Penile -Likeing.j Urol 1994;152:884.

956. Kim ED and McVary KT: Long-term results with penile selection for venogenic impotence.J Urol 1995;153:655.

957. Knoll LD, Furlow WL and Benson RC: Penile Venous ligament surgery for handling caverneous venous leakage.urol int 1992;49:33.

958. Bodyman RF, Lycklama Nijeholt Aaab, Odink HF et al: Treatment of impotence caused by Veno-O-o-occlusive dysfunction with removable balloons and rinsing in combination with resection of the deep dorsal vein: comparison with resection of the deep dorsal vein.1992;10:226.

959. Lewis RW: Work results for Veno-O-o-Occive disease.J Sex Marital Ther 1991;17:129.

960. LUNGLMAY G, NIYALL M AND GINDL K: Long -term results of deep dorsal penisal transection at venous impotence. Urol 1988;15:209.

961. McLoughlin J, Asopa R and Williams G: Surgical treatment of venous leakage: medium -term follow -up.eur Urol 1993;23:352.

962. Miwa Y, Shioyama R, Itou y et al: Pelvic Venoor with ethanol to treat erectile dysfunction as a result of Veno-occlusive dysfunction.urology 2001;58:76.

963. Montague DK, Angermeier KW, Lakin mm et al: follow Penile Veneous lining in 18 patients with 1 to 3 years -Urol 1993;149:306.

964. Motiwala HG, Patel DD, Joshi Sp et al: Experience with venous surgery.urol int 1993;51:9.

965. Net JR Nr, Cara A, Reinato Jas et al: Cavernosometry: Fixing method for surgical treatment of impotence as a result of venous leakage.urology 1990;35:35.

966. FC, Ruan XQ, Wong and et al: Veneuze lining for Kavernous leakage Impotence-a report on 30 cases.Acad with Singapore 1995;24:716.

967. NikooBakht M, Saraji A and Meysamie A: Preoperative Corporal Biopsy as a prediction of postoperative results in venook -colored erectile dysfunction.urol J 2005;2:160.

968. Parrott LH, Shole AH, RICE JC et al.: Penile Vena Disput: an investigation into the effectiveness of the long term by impotence.7:169.

969. Petrou S OG Lewis RW: Management of Corporal Veno-occlusive Dysfunktion.urol Int 1992;49:48.

970. Popkken G, Katzenwadel A and Wetterauer U: Long -term results of dorsal penile vein are left behind for symptomatic treatment of erectile dysfunction.andrologia 1999;31 Suppl 1:77.

971. Rossman B, MIZA M and Melman A: Penile-Angel likes corporal incompetence: an evaluation of short-term and long-term results.J Urol 1990;144:679.

972. Sasso F, Gulino G, Di Pinto a et al: Venous surgery still has to be presented or neglected?8:25.

973. SASSO F, Gulino G, Weir J et al: Criteria for the choice of patient in surgical treatment of Veno-occlusive dysfunction.j Urol 1999;161:1145.

974. Schultheiss D, Truss MC, Becker AJ et al: Long-term results after Back-Vin comparison in 126 patients with VENO-O-occlusive dysfunction.Th J Impot Res 1997;9:205.

975. Stief CG, Djamilian M, Truss Mc et al: Prognostic factors for the postoperative result of penis venous surgery for venogeneous erectile dysfunction.J Urol 1994;151:880.

976. Since ROS CT, counting C, Antonini CC et al: long -term results of Penile Venes League for erectile dysfunction due to Cavernovenøs.tech Urol 2000 disease;6:172.

977. Torok A, Szekely J, Mark B et al: Surgical treatment of impotence due to venous outflow.Int Urol Nephrol 1989;21:485.

978. Treiber U and Gilbert P: Veneuze surgery in erectile dysfunction: a critical report on 116 patients.urology 1989;34:22.

979. TSAI TC, HSU GL, Chen sc et al: Analysis of the results of reconstructive surgery for vasculogenic impotence.Taiwan Yi Xue Hui Za Zhi 1988;87:182.

980. Vale yes, Feneley MR, Lee's Wr et al: Venous leakage Operation: Long -term follows -Up of patients undergoing excision and lie on the deep back of the penis.br J Urol 1995;76:192.

981. Wagenhandel LV: New treatment of raised venous drainage with organic impotence: lining of internal iliac -vener.eur Urol 1989;16:172.

982. Weidner W, Weiske WH, Rudnick J et al: Veneous surgery at Veno-O-O-O-O-O-Oxfunction: Long-term results after deep dorsal vein section.urol int 1992;49:24.

983. Wespes E and Schulman CC: Veneous leakage: Surgical treatment of a Hurtor Reason for impotence. Urol 1985;133:796.

984. Wespes E, Moreira de Goes P, Sattar Aa Eta Al: Objective criteria in the long -term evaluation of the venous surgery of the Penis.J Urol 1994;152:888.

985. Wespes E, Delcour C, Presserowitz L et al: Impotence as a result of corporal Veno-occlusive dysfunction: Long-term follow-up of venous surgery.EUR Urol 1992;21:115.

986. Williams G, Mulcahy MJ, Hartnell G et al: Diagnosis and treatment of venous leakage: a healing cause of impotence.br J Urol 1988;61:151.

987. Yu GW, Schwab FJ, Melograna FS et al: preoperative and post -operative dynamic cavernosography and cavernosometry: objective assessment of venous lings for impotence.J UROL 1992;147:618.

988. Vardi Y, Appel B, Kilchevsky a et al: Has a low intensity of extracorporal shock wave treatment a physiological effect on the erectile function?187:1769.

989. Srini vs, Reddy RK, Shultz et al: Extraoral shock golf therapy with low intensity to erectile dysfunction: a study at an Indian population. Can J Urol 2015;22:7614.

990. Olsen AB, Persiani M, Boie s et al: Can lav -intensive extracoral shock golf treatment improve erectile dysfunction?49:329.

991. Kalyvianakis D and Hatzichristou D: Low-intensity shocking therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: a plywood-based appearance-controlled trial period.j sex with 2017;14:891.

992. Kitrey ND, Gruenwald I, Appel B et195:1550.

993. YEE CH, Chan Es, Hou SS et al: Extracorporal shock wave treatment In the treatment of erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled research.21:1041.

994. Fojecki GL, Tiessen S and Osther PJ: Effect of low-energy-linear shock golf therapy on erectile dysfunction-dubbel blind, with false-controlled, randomized clinical study.J Sex with 2017;14:106.

995 Clavijo Ri, Kohn TP, Kohn Jr et al: Effects of Ekrakororic shock treatment with low intensity on erectile dysfunction: a systematic review and meta -analysis.j sex with 2017;14:27.

996.Hope JC, Arance I, De Las Heras Mm et al: Effectiveness of bump golf treatment with low intensity for erectile dysfunction: a Systatic Review and Meta-Angese.actas Urol Esp 2017;41:479.

997. Lu Z, Lin G, Reed-Maldonado a et al: Extra corporal shock wave treatment at low intensity improves the erectile function: a systematic review and meta-analysis. Urol 2017;71:223.

998. Zj, Tang Ly, Liu Zh et al: Efficiency and safety in the short term with extracoral shock wave treatment with low intensity in erectile dysfunction: a systematic review and meta analysis.Thyt Braz J Urol 2017;43:805.

999. Bahk JY, JUNG JH, HE HT AL: Treatment of diabetic impotence with intraka -neuze transplantation of umbilical cord blood stem cells: provisional report during 7 cases.Exp Clin Transplant 2010;8:150.

1000. Garber MG and Carlos, ND: Intrakaverø's administration of fat stem cells: a new technique for the treatment of erectile dysfunction in diabetic patients, provisional report of 6 cases.MOJ CELL SCI REP 2015;1:0001

1001169:988.

1002. Haahr MK, Jensen CH, Tosyskani NM et al: Safety and potential effect of a single intraka feather injection of autologous fat -Derived regenerative cells in patients with erectile dysfunction after radical prostatectomy: an open phase in clinical study.ebiomedicine 2016;5:204.

1003. Levy yes, Marchand M, Iorio L et al: Determination of the possibility of dealing with erectile dysfunctions with people with placenta derived stem cells.j am osteopath Assoc 2016;116:E1.

1004.http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.

1005.https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html

1006. Carter HB, Albertsen PC, Barry MJ, et al2: 419-426.

1007. Mulhall JP, Trost LW, Brannigan Re et al: Evaluation and treatment of Testosterone -Deficiency: AUA Directive.j Urol 2018; DOI 10.1016/J.Juro.2018.03.115.